rsID,gene,condition,variant_type,consequence,chromosome,position,protein_change,clinical_sig,ref_allele,alt_allele,variant_id,position_clean,gene_primary,chrom_clean,als_subtype,onset_type,onset_age,base_progression,base_impact,phenotype_notes,base_severity,gnomAD_AF,gnomAD_AF_AFR,gnomAD_AF_AMR,gnomAD_AF_EAS,gnomAD_AF_EUR,gnomAD_AF_SAS,severity_score,severity_category,actual_carriers
rs1644506661,PLEKHG5,"Spinal muscular atrophy, lower extremity-predominant (SMA-LED)",single nucleotide variant,missense variant,1,6469588,"P630H, P699H, P707H, P667H",Likely pathogenic,C,A,rs1644506661,6469588.0,PLEKHG5,1,SMA_Related,Juvenile,10-20 years,Slow,0.45,Lower motor neuron predominant; legs affected first,4.0,0.0005462866670553232,0.0005554841072450187,0.0007503713193132079,0.00020461626679903468,0.0006755770736077613,0.0005453845683115939,4.0,Mild,12
rs1435710212,PLEKHG5,"Spinal muscular atrophy, lower extremity-predominant (SMA-LED)",single nucleotide variant,nonsense,1,6470860,"Q550*, Q473*, Q542*, Q510*",Pathogenic,C,T,rs1435710212,6470860.0,PLEKHG5,1,SMA_Related,Juvenile,10-20 years,Slow,0.45,Lower motor neuron predominant; legs affected first,4.0,0.0006737295210356871,0.0009537869024791117,0.00041145353752591646,0.0006911783205733882,0.0008737778616273199,0.00043845098297269885,6.2,Moderate,17
rs1553122918,PARK7,Parkinson disease 7 / ALS modifier,single nucleotide variant,nonsense,1,7965366,Q45*,Pathogenic,C,T,rs1553122918,7965366.0,PARK7,1,ALS_Modifier,Adult,30-50 years,Variable,0.55,Primarily Parkinson disease; may modify ALS phenotype,5.0,0.00033784951247601007,0.0006198627566196895,0.0003188369402220763,0.0002466004706242761,0.00022629818583597266,0.0002776492090780358,7.7,Moderate,5
rs80356723,TARDBP,Amyotrophic lateral sclerosis type 10 (ALS10),single nucleotide variant,missense variant,1,11022292,,Pathogenic,G,A,rs80356723,11022292.0,TARDBP,1,ALS10_Classical,Adult,40-60 years,Moderate,0.75,TDP-43 pathology; may present with FTD features,7.0,0.0013761903679509926,0.002020051876581435,0.001375646488812811,0.0010363189685247646,0.0014038333999256548,0.0010451011059102973,7.7,Moderate,46
rs1304706298,TARDBP,Amyotrophic lateral sclerosis type 10 (ALS10),single nucleotide variant,missense variant,1,11022371,A321D,Likely pathogenic,C,A,rs1304706298,11022371.0,TARDBP,1,ALS10_Classical,Adult,40-60 years,Moderate,0.75,TDP-43 pathology; may present with FTD features,7.0,0.00024358909570820466,0.00020146134450585185,0.00018711089469915216,0.0003749233006052913,0.00014326449004975866,0.00031118544868096923,7.0,Moderate,6
rs80356732,TARDBP,Amyotrophic lateral sclerosis type 10 (ALS10),single nucleotide variant,missense variant,1,11022444,N345K,Pathogenic,C,A,rs80356732,11022444.0,TARDBP,1,ALS10_Classical,Adult,40-60 years,Moderate,0.75,TDP-43 pathology; may present with FTD features,7.0,0.0009412351188690639,0.0012727171764702683,0.0010250493695716434,0.0006439869065772747,0.0007913015033957259,0.000973120638330407,7.7,Moderate,25
rs1643659556,TARDBP,Amyotrophic lateral sclerosis type 10 (ALS10),single nucleotide variant,missense variant,1,11022469,Q354E,Likely pathogenic,C,G,rs1643659556,11022469.0,TARDBP,1,ALS10_Classical,Adult,40-60 years,Moderate,0.75,TDP-43 pathology; may present with FTD features,7.0,0.0017860042787220236,0.0017483668051277593,0.0012465895116194644,0.0017339070423232827,0.002379165007497272,0.00182199302704234,7.0,Moderate,65
rs766196255,TARDBP,Amyotrophic lateral sclerosis type 10 (ALS10),single nucleotide variant,missense variant,1,11022532,S375G,Pathogenic,A,G,rs766196255,11022532.0,TARDBP,1,ALS10_Classical,Adult,40-60 years,Moderate,0.75,TDP-43 pathology; may present with FTD features,7.0,0.000253657675420364,0.00030236934625698324,0.0003445725133865507,0.0002833054136052081,0.00022216904310736962,0.00011587206074570831,7.7,Moderate,8
rs1557660662,TARDBP,Amyotrophic lateral sclerosis type 10 (ALS10),single nucleotide variant,missense variant,1,11022541,N378D,Likely pathogenic,A,G,rs1557660662,11022541.0,TARDBP,1,ALS10_Classical,Adult,40-60 years,Moderate,0.75,TDP-43 pathology; may present with FTD features,7.0,0.001009445565662742,0.0015039528198009756,0.001289322004916615,0.0005285895226526009,0.0006267883353744743,0.0010985751455690447,7.0,Moderate,39
rs1553159739,TARDBP,Amyotrophic lateral sclerosis type 10 (ALS10),single nucleotide variant,missense variant,1,11022542,N378S,Likely pathogenic,A,G,rs1553159739,11022542.0,TARDBP,1,ALS10_Classical,Adult,40-60 years,Moderate,0.75,TDP-43 pathology; may present with FTD features,7.0,0.001041386339145915,0.001086640928162839,0.0015056928365248712,0.0009444538517200395,0.0008669034406848585,0.0008032406386369663,7.0,Moderate,37
rs766653950,DCTN1,Perry syndrome / ALS-Parkinsonism-Dementia complex,single nucleotide variant,missense variant|non-coding transcript variant,2,74361513,"R1258C, R1268C, R1141C, R1250C, R1252C, R1275C, R1136C, R1233C",Likely pathogenic,C,T,rs766653950,74361513.0,DCTN1,2,ALS_Parkinsonism,Adult,40-60 years,Moderate,0.76,"May present with parkinsonism, depression, weight loss, hypoventilation",7.0,0.0015058090108446365,0.0017830057754815063,0.001448361162357522,0.0012282621839980893,0.0011648573545337785,0.0019045585778522864,7.0,Moderate,41
2:74362643 - 74362727,DCTN1,Perry syndrome / ALS-Parkinsonism-Dementia complex,Deletion,splice acceptor variant|splice donor variant,2,74362643 - 74362727,,Likely pathogenic,N,-,2:74362643 - 74362727,74362643.0,DCTN1,2,ALS_Parkinsonism,Adult,40-60 years,Moderate,0.76,"May present with parkinsonism, depression, weight loss, hypoventilation",7.0,0.0003496375556368743,0.00038657501257617936,0.0003989319898944191,0.00021888561649290318,0.0005157995098314113,0.00022799564938945886,9.1,Severe,10
rs1328116832,DCTN1,Perry syndrome / ALS-Parkinsonism-Dementia complex,single nucleotide variant,missense variant|non-coding transcript variant,2,74368122,"I488F, I585F, I599F, I602F, I605F, I615F, I622F",Likely pathogenic,A,T,rs1328116832,74368122.0,DCTN1,2,ALS_Parkinsonism,Adult,40-60 years,Moderate,0.76,"May present with parkinsonism, depression, weight loss, hypoventilation",7.0,0.001000346391995746,0.001602721816230549,0.0008578739449917265,0.0005265278615834151,0.0014391866930111934,0.0005754216441618458,7.0,Moderate,28
rs2529170080,DCTN1,Perry syndrome / ALS-Parkinsonism-Dementia complex,Duplication,frameshift variant|non-coding transcript variant,2,74371555 - 74371556,"L190fs, L76fs, L193fs, L203fs, L210fs, L173fs, L187fs",Pathogenic,N,NN,rs2529170080,74371555.0,DCTN1,2,ALS_Parkinsonism,Adult,40-60 years,Moderate,0.76,"May present with parkinsonism, depression, weight loss, hypoventilation",7.0,0.000214931299967017,0.00023038274143477737,0.00034373363838952466,0.00011672266670511683,0.00016228215048919682,0.00022153530281646938,10.0,Severe,4
rs1553466434,DCTN1,Perry syndrome / ALS-Parkinsonism-Dementia complex,single nucleotide variant,splice donor variant,2,74377998,,Pathogenic,T,C,rs1553466434,74377998.0,DCTN1,2,ALS_Parkinsonism,Adult,40-60 years,Moderate,0.76,"May present with parkinsonism, depression, weight loss, hypoventilation",7.0,0.0002992675409074182,0.000369398421606756,0.0003499688708264269,0.00028344936982512567,0.000273768994571725,0.00021975204770705717,10.0,Severe,9
rs121909342,DCTN1,Perry syndrome / ALS-Parkinsonism-Dementia complex,single nucleotide variant,missense variant|non-coding transcript variant,2,74378104,"G42R, G59R",Pathogenic,G,C,rs121909342,74378104.0,DCTN1,2,ALS_Parkinsonism,Adult,40-60 years,Moderate,0.76,"May present with parkinsonism, depression, weight loss, hypoventilation",7.0,0.00025514922455125295,0.0002326996756968068,0.000264913398648654,0.0003231846232899158,0.0001719434557607699,0.00028300496936011806,7.7,Moderate,6
rs121909342,DCTN1,Perry syndrome / ALS-Parkinsonism-Dementia complex,single nucleotide variant,missense variant|non-coding transcript variant,2,74378104,"G59S, G42S",Pathogenic,G,A,rs121909342,74378104.0,DCTN1,2,ALS_Parkinsonism,Adult,40-60 years,Moderate,0.76,"May present with parkinsonism, depression, weight loss, hypoventilation",7.0,0.00116725455848419,0.001254216236480222,0.001005984560683953,0.0011562492923867663,0.001324084375952507,0.0010957383269175024,7.7,Moderate,31
rs1014953504,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,splice donor variant,2,201704453,,Likely pathogenic,G,A,rs1014953504,201704453.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.000782236992821305,0.0011356621129237645,0.00047458880690063926,0.0008766354825230591,0.0008282359294228969,0.000596062632336166,6.5,Moderate,23
rs1167814155,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Deletion,splice donor variant,2,201704453,,Pathogenic,N,-,rs1167814155,201704453.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,5.5950274818361655e-05,5.297389477274104e-05,4.72952525258866e-05,4.251896940793057e-05,7.139686102990611e-05,6.556639635534393e-05,7.2,Moderate,1
rs1689580631,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,missense variant,2,201704484,P1603L,Likely pathogenic,C,T,rs1689580631,201704484.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0008628538377934104,0.0006933237816090383,0.0005518783258806613,0.0010964059907823162,0.001159304618036995,0.0008133564726580418,5.0,Mild,31
rs1689584119,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Microsatellite,frameshift variant,2,201704537 - 201704538,S1585fs,Likely pathogenic,N,NN,rs1689584119,201704537.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.000288125770078202,0.00046699962228920563,0.00018741711008849466,0.00014331944228821627,0.0004356862322461196,0.00020720644347897374,7.0,Moderate,8
rs1337097412,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Duplication,frameshift variant,2,201706878 - 201706879,I1517fs,Pathogenic,N,NN,rs1337097412,201706878.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00025883770178874874,0.0003494773399860609,0.00032871211951549027,0.00019309452342432547,0.00017658785437567808,0.0002463166716421888,7.7,Moderate,3
rs1391892163,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,nonsense,2,201706898,R1510*,Pathogenic,C,T,rs1391892163,201706898.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,2.5523805825134555e-05,2.267686968459462e-05,1.8644979078874262e-05,3.9627741021152444e-05,1.7734938621800543e-05,2.8934500719250904e-05,7.7,Moderate,1
rs1263013448,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,splice donor variant,2,201707867,,Likely pathogenic,T,A,rs1263013448,201707867.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00017215238719405285,0.00019668195113420694,0.00015054629402309333,0.00013999615317378402,0.00018567295194882362,0.00018786458569035634,6.5,Moderate,12
rs2105969251,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Deletion,frameshift variant,2,201707904,K1457fs,Pathogenic,N,-,rs2105969251,201707904.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00014741627893828934,0.00017162983792283793,0.0001278019187681378,8.857457770260454e-05,0.0001956405595813549,0.0001534345007165114,7.7,Moderate,3
rs2105972075,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,nonsense,2,201709938,L1408*,Pathogenic,T,A,rs2105972075,201709938.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00017163689359369393,0.0002346141648028622,0.00013143160809557956,0.00022188040487612547,0.0001239188835317334,0.00014633940666216905,7.7,Moderate,5
rs1213175712,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,splice acceptor variant,2,201710040,,Likely pathogenic,A,G,rs1213175712,201710040.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.000805223393381286,0.0013315977397034186,0.0008822050407994894,0.0006242499755818149,0.0008077501305956529,0.00038031408022605386,6.5,Moderate,29
rs770096661,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Deletion,frameshift variant,2,201711049,Q1355fs,Likely pathogenic,N,-,rs770096661,201711049.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0006245111193087544,0.0008343458726130644,0.0007311717360967062,0.00037095082165864503,0.0007161778630508383,0.0004699093031245181,7.0,Moderate,24
rs1690335308,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,splice donor variant,2,201715671,,Likely pathogenic,G,A,rs1690335308,201715671.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.001039640832177063,0.0015834813522440476,0.0008687802939938694,0.0010470056399243866,0.0005983391413062406,0.001100597733416771,6.5,Moderate,30
rs2469724450,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Deletion,frameshift variant,2,201715783,D1298fs,Likely pathogenic,N,-,rs2469724450,201715783.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00015431951017466395,0.0001984633769832094,0.00011645881632963502,0.00011548907415152042,0.0001565603064250065,0.0001846259769839484,7.0,Moderate,5
rs1690523978,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,nonsense,2,201718084,K1277*,Pathogenic,A,T,rs1690523978,201718084.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0007171018300621081,0.0009924622254613076,0.0005821530310691176,0.000713397162500878,0.0005017190144648745,0.0007957777168143628,7.7,Moderate,25
rs2469734144,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Duplication,frameshift variant,2,201718113 - 201718114,S1267fs,Pathogenic,N,NN,rs2469734144,201718113.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00045261618780077176,0.0005875917549948232,0.0004959244109309331,0.00025330455081300327,0.00032747525201373576,0.0005987849702513633,7.7,Moderate,14
rs1690532210,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,splice acceptor variant,2,201718212,,Pathogenic,A,C,rs1690532210,201718212.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,9.46583769227593e-05,0.00012261022188102296,9.922419832031394e-05,4.575731081444852e-05,9.68457994388867e-05,0.00010885435415912438,7.2,Moderate,4
2:201723059,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,nonsense,2,201723059,W1229*,Likely pathogenic,G,A,2:201723059,201723059.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0008061060424462719,0.0008217506816949366,0.000630972078282029,0.0008892978802712359,0.00045368546234688685,0.0012348241096362706,7.0,Moderate,18
rs2105998730,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,splice donor variant,2,201723329,,Likely pathogenic,G,A,rs2105998730,201723329.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0008190023374939331,0.0011634737517053951,0.0007934846452582979,0.000608558075186457,0.0009158285887820311,0.0006136666265374839,6.5,Moderate,30
rs386134187,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Deletion,genic downstream transcript variant|nonsense,2,201723335,,Pathogenic,N,-,rs386134187,201723335.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0004132923585232772,0.00032729995297669937,0.0004593675827458598,0.0003105189588997566,0.000488974795635185,0.0004803005023588855,7.7,Moderate,9
rs1574698048,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,nonsense,2,201723371,G1195*,Pathogenic,G,T,rs1574698048,201723371.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00011571369351232922,0.00010863352968051062,8.40752358978078e-05,0.00013229253993495945,0.00010938049972425538,0.00014418666232411288,7.7,Moderate,4
rs2469758488,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Indel,frameshift variant,2,201723437 - 201723438,E1173fs,Likely pathogenic,N,-,rs2469758488,201723437.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,8.516845699765776e-05,9.671017087340919e-05,9.061231514036617e-05,6.43813264111391e-05,0.00010654133912328232,6.759713344009195e-05,7.0,Moderate,1
rs1317051984,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Deletion,splice acceptor variant,2,201723437,,Pathogenic,G,-,rs1317051984,201723437.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00021236174244827028,0.00024965208618747795,0.00017873473475222415,0.0002583893471267713,0.0001936239695121835,0.00018140857466269466,7.2,Moderate,9
rs2105999102,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,splice acceptor variant,2,201723442,,Pathogenic,G,A,rs2105999102,201723442.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00035028470111550487,0.0005218095659344215,0.00046395565801506545,0.0002713505308074771,0.0003033828934461717,0.00019092485737438864,7.2,Moderate,11
rs2469758597,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,splice acceptor variant,2,201723443,,Likely pathogenic,A,T,rs2469758597,201723443.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.000431140726222284,0.0003949998104791706,0.00045399312188021266,0.00032836520109502004,0.0004993209067176576,0.00047902459093935934,6.5,Moderate,16
rs2106001462,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,splice acceptor variant,2,201724460,,Likely pathogenic,G,A,rs2106001462,201724460.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0011255287870745756,0.0013043521383909904,0.0010124450229666987,0.0012767575307515325,0.0005935447798655104,0.0014405444633981464,6.5,Moderate,34
rs2469768159,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,splice acceptor variant,2,201725456,,Likely pathogenic,A,T,rs2469768159,201725456.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0005181500672698292,0.0007707487404393194,0.0005297732222335925,0.0003893908483830974,0.000451181788300668,0.00044965573699246904,6.5,Moderate,17
rs2106005949,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,splice donor variant,2,201726483,,Likely pathogenic,G,C,rs2106005949,201726483.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.000861627325803989,0.0007716811940174338,0.000999251170965083,0.0007475863254348037,0.001228820734830127,0.000560797203772498,6.5,Moderate,26
rs2106005949,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,splice donor variant,2,201726483,,Likely pathogenic,G,T,rs2106005949,201726483.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0007421903932035863,0.0006561578152103773,0.0008273488821222264,0.0010119523849097518,0.0008016193348224871,0.00041387354895308897,6.5,Moderate,31
rs2106005994,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,missense variant,2,201726511,G1074D,Pathogenic,G,A,rs2106005994,201726511.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00047939899122875676,0.00036697383912701027,0.0005494123336852898,0.00035489956164744534,0.00046853077013934226,0.0006571784515446965,5.5,Mild,13
2:201726551,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,splice acceptor variant,2,201726551,,Likely pathogenic,A,G,2:201726551,201726551.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0005826226606477148,0.0008472208339580897,0.0004890522960971426,0.00039543210953983795,0.0005148591321214307,0.0006665489315220728,6.5,Moderate,25
rs1691183538,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,missense variant,2,201726685,L1054P,Likely pathogenic,T,C,rs1691183538,201726685.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.002318052541429517,0.003040382629502627,0.002789734851210696,0.0014689857728830385,0.002116659166068993,0.0021745002874822305,5.0,Mild,60
rs2469774653,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,nonsense,2,201726776,Q1024*,Pathogenic,C,T,rs2469774653,201726776.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.000265197755460264,0.0003091586885121703,0.00028574473541186296,0.0001968512238027478,0.00026447000196459547,0.0002697641276099434,7.7,Moderate,11
rs2469780591,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,nonsense,2,201727737,W960*,Pathogenic,G,A,rs2469780591,201727737.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00032064680400893,0.00043295742083032505,0.0004933954875634358,0.0002747564079377949,0.0001760773107914598,0.0002260473929216348,7.7,Moderate,5
rs2106009582,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,splice acceptor variant,2,201727777,,Likely pathogenic,A,G,rs2106009582,201727777.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.000131955767473389,0.00018055284913177233,0.00010568370668925036,0.00014615037326603386,8.537112623415978e-05,0.00014202078204572863,6.5,Moderate,5
rs2469784078,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,nonsense,2,201728514,Q947*,Pathogenic,C,T,rs2469784078,201728514.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00027024552950805514,0.0003807355171874254,0.000188343153458088,0.00014842414338518166,0.0001618020477035291,0.0004719227858060517,7.7,Moderate,5
rs2106011709,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,splice acceptor variant,2,201728642,,Pathogenic,A,C,rs2106011709,201728642.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00038269339823421696,0.0002822085736478175,0.00026788941706590525,0.0005894028957059386,0.0005075369809894566,0.000266429123761967,7.2,Moderate,21
rs2106012637,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Duplication,frameshift variant,2,201729056 - 201729057,M903fs,Pathogenic,N,NN,rs2106012637,201729056.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0006326940015127652,0.0007558648557134258,0.0007489582382994277,0.0004098318352446219,0.0005574357389480032,0.0006913793393583476,7.7,Moderate,23
rs767762611,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Duplication,frameshift variant,2,201729063 - 201729064,G901fs,Likely pathogenic,N,NN,rs767762611,201729063.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0005013571964527501,0.00043249347354813825,0.0008034272374781219,0.00040107272904795095,0.0005286866899771637,0.0003411058522123758,7.0,Moderate,13
rs745657866,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,nonsense,2,201733329,R843*,Pathogenic,C,T,rs745657866,201733329.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00016700718041597136,0.0001235218886910737,0.00014166648585348422,0.00015724173886345156,0.00020340816367654432,0.00020919762499530307,7.7,Moderate,4
rs1275973309,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,splice donor variant,2,201738669,,Pathogenic,G,C,rs1275973309,201738669.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0002503001711663328,0.00041043044423672096,0.0002787258519677381,0.0002189214766731068,0.00016113547668711062,0.00018228760626698754,7.2,Moderate,5
rs759408917,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,nonsense,2,201741804,R741*,Pathogenic,C,T,rs759408917,201741804.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00017112224117149643,0.00014753422514595074,0.00010183546304620522,0.0001859213879939867,0.0002678442424593911,0.00015247588721194847,7.7,Moderate,7
rs2469852909,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Duplication,frameshift variant,2,201744259 - 201744260,L723fs,Likely pathogenic,N,NN,rs2469852909,201744259.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0002417611142352138,0.00021347274076229935,0.00029426269014224153,0.00022764621843687562,0.0001891755155305378,0.0002842484063041146,7.0,Moderate,8
rs1574748038,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,nonsense,2,201744324,E702*,Likely pathogenic,G,T,rs1574748038,201744324.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0006340655275039854,0.0009022622438835522,0.0004804422286439494,0.00037197510153103827,0.0008765705291095145,0.0005390775343518726,7.0,Moderate,19
rs1692492382,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Deletion,frameshift variant,2,201744402 - 201744412,V673fs,Pathogenic,N,-,rs1692492382,201744402.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0006365086564917072,0.000503752110926389,0.0005815047938426005,0.0004279436058046098,0.000697552841783182,0.0009717899301017549,7.7,Moderate,16
rs1553511680,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,nonsense,2,201746643,Q641*,Pathogenic,C,T,rs1553511680,201746643.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00045554065508341394,0.00040469809841433684,0.0005903988057403162,0.00037061576001895123,0.0005642853835455694,0.0003477052276978959,7.7,Moderate,9
rs863225294,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,nonsense,2,201746653,Y637*,Likely pathogenic,C,A,rs863225294,201746653.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0007131644150982819,0.0006604434408415534,0.0006869979435438661,0.0006742796611839002,0.0008165233245320656,0.0007275777053900238,7.0,Moderate,14
rs386134181,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Deletion,genic downstream transcript variant|frameshift variant,2,201746696 - 201746697,L623fs,Pathogenic,N,-,rs386134181,201746696.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0005542142949154736,0.0004929154537612808,0.0005763151584969051,0.0005540866289530104,0.0007365969826159687,0.0004111572507502026,7.7,Moderate,18
rs1060503672,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,splice acceptor variant,2,201746749,,Likely pathogenic,G,A,rs1060503672,201746749.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0005675372143735802,0.0008748640020396504,0.000625631148359338,0.0004031582694177676,0.00036250443745696224,0.0005715282145941825,6.5,Moderate,15
rs2106074302,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Deletion,frameshift variant,2,201754521,H541fs,Pathogenic,N,-,rs2106074302,201754521.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0005801867845365925,0.0006780222758216744,0.0005883553431210146,0.0007141561616282329,0.00026458471476225356,0.0006558154273497863,7.7,Moderate,22
2:201754609 - 201754610,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Duplication,frameshift variant,2,201754609 - 201754610,T512fs,Pathogenic,N,NN,2:201754609 - 201754610,201754609.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0004029593557739972,0.0005092699916717983,0.0005995344865020977,0.00020311919897927384,0.0002982495934078938,0.0004046235083089223,7.7,Moderate,13
rs1693462968,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,splice donor variant,2,201757401,,Likely pathogenic,G,A,rs1693462968,201757401.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,6.662715727872765e-05,6.791346445061084e-05,5.905045444129233e-05,9.02240056260235e-05,6.643427608876766e-05,4.951358578694395e-05,6.5,Moderate,2
rs878855058,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Deletion,frameshift variant,2,201757445 - 201757448,G477fs,Pathogenic,N,-,rs878855058,201757445.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0006595182416609578,0.0009905998806741358,0.0005123462692621568,0.0006974987602282342,0.0005166286974174942,0.0005805176007227679,7.7,Moderate,17
rs2469899610,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Deletion,frameshift variant,2,201757546 - 201757552,I441fs,Likely pathogenic,N,-,rs2469899610,201757546.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00010908642810324577,0.00014357311539665946,0.00015671333417156003,0.00010230187809626151,7.874291328941194e-05,6.410089956233594e-05,7.0,Moderate,1
2:201757623,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,nonsense,2,201757623,S417*,Pathogenic,C,G,2:201757623,201757623.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.000649574047658427,0.0005925370989655742,0.0004755662486279156,0.0006764796750600223,0.0009762891497923335,0.0005269980658462897,7.7,Moderate,20
rs2469900041,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,nonsense,2,201757623,S417*,Likely pathogenic,C,A,rs2469900041,201757623.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0006056724987232198,0.0009765105097308056,0.0005978900965919634,0.0003551751031524581,0.000441730764521228,0.0006570560196196435,7.0,Moderate,15
rs2106080813,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,splice acceptor variant,2,201757760,,Likely pathogenic,G,A,rs2106080813,201757760.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00016895010390527283,0.0002076955641003582,0.00022355168020180545,0.00010357704604028148,0.00017590704516335658,0.00013401918402056244,6.5,Moderate,6
2:201760880,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Deletion,frameshift variant|splice donor variant,2,201760880,V372fs,Pathogenic,N,-,2:201760880,201760880.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00044151209734706294,0.0005995774728942629,0.00038685787320533275,0.0005740211185003483,0.00024368938541440344,0.0004034146367209672,7.7,Moderate,17
rs1693726956,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,nonsense,2,201760950,Y348*,Pathogenic,C,G,rs1693726956,201760950.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0007207749822446912,0.001044387540091372,0.0005311059480512071,0.0007692671844627036,0.000520292381049108,0.000738821857569065,7.7,Moderate,25
rs386134175,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Deletion,frameshift variant,2,201760986 - 201760987,I336fs,Pathogenic,N,-,rs386134175,201760986.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0005459991881536566,0.0005678118976583571,0.0005381732924092514,0.0004104739485277453,0.0005112750031510783,0.000702261799021851,7.7,Moderate,18
rs2469913984,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Deletion,frameshift variant,2,201761017,G326fs,Pathogenic,N,-,rs2469913984,201761017.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.000464214980094658,0.0004887416572641446,0.00041925267370855287,0.0006132820729774894,0.0002977614392129886,0.0005020370573101144,7.7,Moderate,13
rs1574786641,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Deletion,nonsense,2,201761081,,Pathogenic,N,-,rs1574786641,201761081.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00046191104341315275,0.0005466353622633961,0.0004875267571541165,0.00028335123887333045,0.0006645374562698317,0.00032750440250508905,7.7,Moderate,17
rs2106088185,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Deletion,frameshift variant,2,201761130,V289fs,Pathogenic,N,-,rs2106088185,201761130.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00012309146628111163,0.00011227677354039803,0.00012595097592192687,0.00011326835192894818,0.00014714585922335723,0.00011681537079092773,7.7,Moderate,6
rs767032589,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,nonsense,2,201761353,L214*,Pathogenic,T,G,rs767032589,201761353.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0006588184408734147,0.0010141129302094186,0.0005267189435019549,0.00039630143509391093,0.0007953722404047729,0.0005615866551570163,7.7,Moderate,22
rs386134174,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Deletion,frameshift variant,2,201761441,T185fs,Pathogenic,N,-,rs386134174,201761441.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.00032456752550062614,0.0003082382248005,0.00043411529692510007,0.00026398408338717063,0.00022063725988640047,0.0003958627625039595,7.7,Moderate,15
rs2469917312,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,nonsense,2,201761534,Q154*,Pathogenic,C,T,rs2469917312,201761534.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,3.8436976252949706e-05,3.149313670446786e-05,4.29999058879798e-05,3.6383823128582304e-05,4.968730440817597e-05,3.1620711135542616e-05,7.7,Moderate,1
rs2106089689,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,missense variant,2,201761647,G116E,Pathogenic,G,A,rs2106089689,201761647.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0005094446372845487,0.0005672935335162488,0.0005590933374273594,0.0002754517479458969,0.0006965826353181217,0.00044880193221511616,5.5,Mild,15
rs2106089798,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Deletion,frameshift variant,2,201761668,N109fs,Pathogenic,N,-,rs2106089798,201761668.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0005780154275839104,0.000542807900178053,0.00046084079180160644,0.0008637571149498794,0.0005962615128837708,0.0004264098181062424,7.7,Moderate,17
rs1693780539,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Microsatellite,frameshift variant,2,201761718 - 201761719,Y92fs,Pathogenic,N,-,rs1693780539,201761718.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0002455276824130332,0.00018556201615891932,0.0002540295279865536,0.00025701015836950946,0.0002887859151721326,0.00024225079437805108,7.7,Moderate,3
rs2106102271,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,Deletion,inframe_deletion,2,201767244 - 201767246,G53del,Pathogenic,N,-,rs2106102271,201767244.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0007742299040656598,0.0006285508561690125,0.0005470439255969589,0.0004787320328838137,0.0012723969180597266,0.0009444257876187874,6.3,Moderate,24
2:201767259,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,missense variant,2,201767259,G49R,Pathogenic,G,A,2:201767259,201767259.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.0013560016732512173,0.0014422959545519847,0.001660146278004322,0.0013875909020901254,0.0011996519810523376,0.0010903232505573167,5.5,Mild,37
rs2469943073,ALS2,Amyotrophic lateral sclerosis type 2 (ALS2) - Juvenile,single nucleotide variant,nonsense,2,201767290,W38*,Pathogenic,G,A,rs2469943073,201767290.0,ALS2,2,ALS2_Juvenile,Juvenile,3-20 years,Slow,0.55,Autosomal recessive; ascending paralysis; slower progression,5.0,0.000751151956558092,0.001192682245276256,0.0007759857677316607,0.0003896368844837689,0.0010179363166668129,0.00037951856863196147,7.7,Moderate,11
rs371332509,ERBB4,Amyotrophic lateral sclerosis type 19 (ALS19),single nucleotide variant,missense variant,2,211383728,"G1256R, G1272R",Likely pathogenic,G,A,rs371332509,211383728.0,ERBB4,2,ALS19_Classical,Adult,40-60 years,Slow,0.55,May have slower progression than typical ALS,5.0,0.0008531079374608184,0.00119513957865958,0.0006276354523202676,0.000663900617984451,0.0004926769080846979,0.0012861871302550952,5.0,Mild,28
2:211387943,ERBB4,Amyotrophic lateral sclerosis type 19 (ALS19),single nucleotide variant,intron variant|splice donor variant,2,211387943,,Likely pathogenic,T,C,2:211387943,211387943.0,ERBB4,2,ALS19_Classical,Adult,40-60 years,Slow,0.55,May have slower progression than typical ALS,5.0,0.0010478087401497229,0.0011602321648766462,0.0010354641195979744,0.0005909541904863263,0.0013492252295337099,0.0011031679962539575,6.5,Moderate,36
rs368743618,TUBA4A,Amyotrophic lateral sclerosis type 22 (ALS22),single nucleotide variant,missense variant,2,219250552,"A383T, A368T",Likely pathogenic,G,A,rs368743618,219250552.0,TUBA4A,2,ALS22_Classical,Adult,50-70 years,Moderate,0.68,Rare; microtubule dynamics,6.0,0.0016354050132654882,0.0021391691051313956,0.0021791724188215214,0.001359641813103939,0.0013347189766673949,0.001164322752603189,6.0,Moderate,48
3:87253797,CHMP2B,Amyotrophic lateral sclerosis type 17 (ALS17),single nucleotide variant,missense variant,3,87253797,"Q165P, Q206P, Q238P",Likely pathogenic,A,C,3:87253797,87253797.0,CHMP2B,3,ALS17_FTD,Adult,40-60 years,Moderate,0.75,Often associated with frontotemporal dementia,7.0,0.0009876514719869142,0.0010072728974759439,0.0006784173011715722,0.0005025767691916142,0.001398466788162461,0.0013515236039329797,7.0,Moderate,35
4:169438207,NEK1,Amyotrophic lateral sclerosis susceptibility (NEK1),Deletion,frameshift variant|non-coding transcript variant|intron variant,4,169438207,"V784fs, V809fs, V836fs, V837fs, V853fs, V881fs",Likely pathogenic,N,-,4:169438207,169438207.0,NEK1,4,ALS_Risk,Adult,50-65 years,Variable,0.65,Risk modifier; DNA damage response pathway,6.0,0.00043493541699439215,0.0005143843697680318,0.0002652855839031141,0.00046704798841765865,0.0005848936581305021,0.0003430654847526541,8.4,Severe,17
rs1744312712,NEK1,Amyotrophic lateral sclerosis susceptibility (NEK1),single nucleotide variant,nonsense|non-coding transcript variant,4,169463291,"E745*, E750*, E775*, E802*, E803*, E819*, E847*",Likely pathogenic,G,T,rs1744312712,169463291.0,NEK1,4,ALS_Risk,Adult,50-65 years,Variable,0.65,Risk modifier; DNA damage response pathway,6.0,0.00021670433688625039,0.0002851957565413637,0.00015513146305702057,0.00019525477493097801,0.00025943261822381115,0.0001885070716780785,8.4,Severe,6
rs750159428,NEK1,Amyotrophic lateral sclerosis susceptibility (NEK1),Microsatellite,nonsense|non-coding transcript variant,4,169477275 - 169477276,,Likely pathogenic,N,-,rs750159428,169477275.0,NEK1,4,ALS_Risk,Adult,50-65 years,Variable,0.65,Risk modifier; DNA damage response pathway,6.0,0.0007496051988293144,0.000732709962788563,0.0010787010122609486,0.0004396329128900867,0.0006771465473116325,0.0008198355588953415,8.4,Severe,19
rs2546553407,NEK1,Amyotrophic lateral sclerosis susceptibility (NEK1),single nucleotide variant,nonsense|non-coding transcript variant,4,169508277,"Q505*, Q530*, Q532*, Q557*, Q558*, Q574*, Q602*",Likely pathogenic,C,T,rs2546553407,169508277.0,NEK1,4,ALS_Risk,Adult,50-65 years,Variable,0.65,Risk modifier; DNA damage response pathway,6.0,0.0003474970586181373,0.0005105642548086798,0.00026552368465611076,0.00017917963084133234,0.0002992794023782928,0.0004829383204062707,8.4,Severe,12
4:169508778 - 169508779,NEK1,Amyotrophic lateral sclerosis susceptibility (NEK1),Deletion,frameshift variant|intron variant,4,169508778 - 169508779,"K536fs, K580fs",Likely pathogenic,N,-,4:169508778 - 169508779,169508778.0,NEK1,4,ALS_Risk,Adult,50-65 years,Variable,0.65,Risk modifier; DNA damage response pathway,6.0,0.0005336021732347921,0.0004894430489269953,0.000707682887357021,0.0003770149696695166,0.0005817829854828582,0.0005120869747375689,8.4,Severe,11
rs371575563,NEK1,Amyotrophic lateral sclerosis susceptibility (NEK1),single nucleotide variant,nonsense|non-coding transcript variant,4,169537826,"R550*, R506*, R481*, R508*, R533*",Pathogenic,C,T,rs371575563,169537826.0,NEK1,4,ALS_Risk,Adult,50-65 years,Variable,0.65,Risk modifier; DNA damage response pathway,6.0,0.00021557141944721585,0.00022622977331227342,0.00029200387848019136,0.0001474050469212133,0.00021992359911299355,0.00019229479940940762,9.2,Severe,3
rs969452649,NEK1,Amyotrophic lateral sclerosis susceptibility (NEK1),single nucleotide variant,nonsense|non-coding transcript variant,4,169555948,"R430*, R447*, R455*, R472*",Likely pathogenic,C,T,rs969452649,169555948.0,NEK1,4,ALS_Risk,Adult,50-65 years,Variable,0.65,Risk modifier; DNA damage response pathway,6.0,0.0007811451877478804,0.0012306843850798247,0.0005266919155339595,0.0009115025197974604,0.0006717302814210816,0.0005651168369070764,8.4,Severe,21
rs2546764617,NEK1,Amyotrophic lateral sclerosis susceptibility (NEK1),single nucleotide variant,nonsense|non-coding transcript variant,4,169556038,"Q400*, Q417*, Q425*, Q442*",Likely pathogenic,C,T,rs2546764617,169556038.0,NEK1,4,ALS_Risk,Adult,50-65 years,Variable,0.65,Risk modifier; DNA damage response pathway,6.0,0.0004577039949305378,0.0006069246099302583,0.0006317856133095591,0.0002946975604720961,0.0003324720758930189,0.0004226401150477566,8.4,Severe,9
4:169556044,NEK1,Amyotrophic lateral sclerosis susceptibility (NEK1),single nucleotide variant,nonsense|non-coding transcript variant,4,169556044,"R398*, R440*, R423*, R415*",Pathogenic,C,T,4:169556044,169556044.0,NEK1,4,ALS_Risk,Adult,50-65 years,Variable,0.65,Risk modifier; DNA damage response pathway,6.0,0.0006163344957045571,0.0007412236248060741,0.0004215358792251096,0.0007741774515494267,0.0006265480053848259,0.0005181875175573493,9.2,Severe,17
rs370576859,NEK1,Amyotrophic lateral sclerosis susceptibility (NEK1),single nucleotide variant,splice donor variant,4,169587558,,Likely pathogenic,G,C,rs370576859,169587558.0,NEK1,4,ALS_Risk,Adult,50-65 years,Variable,0.65,Risk modifier; DNA damage response pathway,6.0,0.0003619148207676539,0.00036950910037172635,0.0002678415016373746,0.0004237279384070949,0.0003295775033846902,0.00041891806003738354,7.8,Moderate,11
rs2480199584,LOC129995449|SQSTM1,"Amyotrophic lateral sclerosis, unspecified type",Indel,intron variant|splice donor variant,5,179821121 - 179821189,,Likely pathogenic,N,-,rs2480199584,179821121.0,LOC129995449,5,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,5.0348489814401664e-05,5.661196085051613e-05,4.439023623071982e-05,3.0248659204407575e-05,6.771461959730877e-05,5.277697318905602e-05,7.8,Moderate,1
rs1757759029,LOC129995449|SQSTM1,"Amyotrophic lateral sclerosis, unspecified type",single nucleotide variant,intron variant|splice donor variant,5,179821143,,Likely pathogenic,T,C,rs1757759029,179821143.0,LOC129995449,5,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.0004981476688667427,0.0004741856833608019,0.0005872268870787119,0.0004660269212704814,0.0006049499487099944,0.0003583489039137243,7.8,Moderate,7
rs373306317,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,single nucleotide variant,splice acceptor variant,5,179822956,,Likely pathogenic,A,G,rs373306317,179822956.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.00031579582890892566,0.00041196843417448957,0.0002832041081709583,0.00029237800857484037,0.00020161723006910671,0.00038981136355523355,7.8,Moderate,8
5:179822957,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,single nucleotide variant,splice acceptor variant,5,179822957,,Likely pathogenic,G,C,5:179822957,179822957.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.0005929480257178229,0.0004153324248746568,0.0005788673189628366,0.0006367216837473032,0.0006878412358743455,0.0006459774651299727,7.8,Moderate,17
rs1425863340,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,single nucleotide variant,5 prime UTR variant|nonsense,5,179822996,E82*,Pathogenic,G,T,rs1425863340,179822996.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,7.160671272937376e-05,0.00010305481394097447,0.00010743047429800062,3.6029030625954724e-05,5.523952773892413e-05,5.6279717043014856e-05,9.2,Severe,1
rs2480208932,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,Insertion,frameshift variant,5,179823011 - 179823012,"M3fs, M87fs",Pathogenic,-,ATGCCTTTTCCAGTGACGAGGAATTGACGAGGAAT,rs2480208932,179823011.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,2.713611605141926e-05,2.8184987692695917e-05,2.0177641398105533e-05,3.4100537865830314e-05,2.3320666374437215e-05,2.9896746926027332e-05,9.2,Severe,1
rs1008679317,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,Duplication,frameshift variant,5,179823859 - 179823860,"E104fs, E20fs",Pathogenic,N,NN,rs1008679317,179823859.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.0004683220209706237,0.0004328206305758324,0.0005244279517073952,0.0005448082863927333,0.00033238299243264755,0.0005071702437445102,9.2,Severe,13
5:179824221,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,single nucleotide variant,nonsense,5,179824221,"G107*, G191*",Pathogenic,G,T,5:179824221,179824221.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.000640769935172081,0.0007964792859793534,0.0005548488314530709,0.0005758639409691455,0.0005888268947156281,0.0006878307227432075,9.2,Severe,29
5:179824266 - 179824267,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,Deletion,frameshift variant,5,179824266 - 179824267,"W122fs, W206fs",Pathogenic,N,-,5:179824266 - 179824267,179824266.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.00018826688015629832,0.00012654676800978584,0.00024870722283202565,8.288923895579786e-05,0.00023109398064621566,0.00025209719033766664,9.2,Severe,8
5:179825158,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,single nucleotide variant,nonsense,5,179825158,"S145*, S229*",Pathogenic,C,A,5:179825158,179825158.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,8.524064985596157e-05,8.942802685820903e-05,8.250090099155753e-05,8.652239226512572e-05,9.027076309138633e-05,7.748116607352925e-05,9.2,Severe,2
rs2480243842,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,Duplication,frameshift variant,5,179833039 - 179833040,"V171fs, V255fs",Pathogenic,N,NN,rs2480243842,179833039.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.000548299265849651,0.0007263740231538133,0.0004518240314737883,0.0007656078756559406,0.00039898964802825257,0.0003987007509364601,9.2,Severe,15
rs1758316662,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,Deletion,frameshift variant,5,179833083,"V187fs, V271fs",Pathogenic,N,-,rs1758316662,179833083.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.00012636018684316204,0.00017779089685706256,0.00010601348532733934,0.00013775069258881902,5.57844315408074e-05,0.00015446142790178198,9.2,Severe,2
rs2480244186,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,Deletion,nonsense,5,179833092 - 179833095,,Pathogenic,N,-,rs2480244186,179833092.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.0005640855797024955,0.0005092998443628686,0.0007485538939782961,0.0006351672336245273,0.0005889309636288666,0.00033847596291791877,9.2,Severe,15
rs2480244231,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,single nucleotide variant,nonsense,5,179833097,"E190*, E274*",Pathogenic,G,T,rs2480244231,179833097.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.0004796830052581286,0.0006649106207602057,0.0005736532304618433,0.00024645987261675883,0.0002894839145281317,0.0006239073879237032,9.2,Severe,8
rs1258386028,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,single nucleotide variant,nonsense,5,179833178,"E217*, E301*",Pathogenic,G,T,rs1258386028,179833178.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.0003783881239434495,0.0006119608120652598,0.0004332506455900108,0.00018985340278618255,0.00040321523407694805,0.00025366052519884644,9.2,Severe,10
rs2113512370,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,single nucleotide variant,splice acceptor variant,5,179833585,,Likely pathogenic,A,G,rs2113512370,179833585.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.0006584681364880541,0.001115666846028903,0.0005793051144543585,0.00044713219396357696,0.000488470305961686,0.0006617662220317459,7.8,Moderate,17
rs1758351897,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,single nucleotide variant,nonsense,5,179833590,"Q241*, Q325*",Pathogenic,C,T,rs1758351897,179833590.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.00020089590756098202,0.0003456476070228828,0.0002000372399108388,0.0002115781548302871,0.00011004250143819743,0.00013717403460270403,9.2,Severe,6
rs2113512406,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,Duplication,frameshift variant,5,179833594 - 179833595,"E327fs, E243fs",Pathogenic,N,NN,rs2113512406,179833594.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.00022229323936725048,0.00024078342139400674,0.00024037245360649116,0.00028251704614212477,0.00014539734301806327,0.00020239593267556635,9.2,Severe,5
rs1185406298,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,single nucleotide variant,nonsense,5,179833612,"S248*, S332*",Pathogenic,C,G,rs1185406298,179833612.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.0001045201220772493,0.00013176209546486472,0.00015661970717798502,5.789668844624918e-05,6.829836098398572e-05,0.000108023758313162,9.2,Severe,2
rs1261101487,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,single nucleotide variant,nonsense,5,179833728,"Q287*, Q371*",Pathogenic,C,T,rs1261101487,179833728.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.0002983581254317801,0.00022970577239636204,0.00025376655096178845,0.0002480027341148615,0.0003966000636698841,0.0003637155060160046,9.2,Severe,9
rs1758359961,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,Deletion,frameshift variant,5,179833743,,Likely pathogenic,N,-,rs1758359961,179833743.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.0009585221191350055,0.0013446831788533104,0.0011193228419547193,0.0005575266703548163,0.0008111610916868848,0.0009599168128252964,8.4,Severe,26
5:179833760 - 179833761,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,Duplication,frameshift variant,5,179833760 - 179833761,"L298fs, L382fs",Likely pathogenic,N,NN,5:179833760 - 179833761,179833760.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.00022177745050590728,0.00031845080300519827,0.00028935681579749027,0.00012803160822177703,0.00025186864065989914,0.00012117938484517173,8.4,Severe,5
5:179833778 - 179833779,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,Duplication,frameshift variant,5,179833778 - 179833779,"E305fs, E389fs",Likely pathogenic,N,NN,5:179833778 - 179833779,179833778.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.0009481164239629267,0.0010612496312125724,0.0010099703211434994,0.0008357574296849399,0.0006527092057902077,0.0011808955319834136,8.4,Severe,25
rs1391182750,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,single nucleotide variant,missense variant,5,179833782,"E305Q, E389Q",Pathogenic,G,C,rs1391182750,179833782.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.001384759562365921,0.0018329684335267743,0.0016566815576368593,0.0006031265385253939,0.0011705485770842584,0.0016604727050563172,6.6,Moderate,43
rs796051870,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,single nucleotide variant,splice donor variant,5,179833783,,Pathogenic,G,A,rs796051870,179833783.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.0006289038858801716,0.0005571685211731519,0.0007780979631220384,0.000379610583969166,0.0007818170764009857,0.0006478252847355161,8.6,Severe,25
rs2480264715,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,Deletion,frameshift variant,5,179836443,"P392fs, P308fs",Pathogenic,N,-,rs2480264715,179836443.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,7.716421268488273e-05,9.838168866458732e-05,6.609485273366815e-05,6.27436378964167e-05,7.844195936906862e-05,8.015892476067288e-05,9.2,Severe,3
5:179836448 - 179837234,SQSTM1|LOC112997583,Amyotrophic lateral sclerosis with Paget disease of bone,Deletion,frameshift variant,5,179836448 - 179837234,"L310fs, L394fs",Likely pathogenic,N,-,5:179836448 - 179837234,179836448.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.0008383513446702245,0.0007935919083226922,0.0006730014429905856,0.0007524296370182546,0.0010122132105002696,0.0009605205245193204,8.4,Severe,32
rs1254158201,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,Duplication,nonsense,5,179836453 - 179836454,"E312*, E396*",Pathogenic,N,NN,rs1254158201,179836453.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.0005969263786246282,0.0006508268536396685,0.0005145394303827913,0.0009115223411387102,0.0005527126429660647,0.00035503062499590566,9.2,Severe,24
rs1247551175,SQSTM1,Amyotrophic lateral sclerosis with Paget disease of bone,single nucleotide variant,missense variant,5,179836481,"M320T, M404T",Pathogenic,T,C,rs1247551175,179836481.0,SQSTM1,5,ALS_Multisystem,Adult,50-70 years,Variable,0.7,May present with Paget disease; autophagy pathway,6.0,0.000412049767569309,0.0005233746952852337,0.0004595187015029093,0.00038942918085075484,0.0001844192342220825,0.0005035070259855648,6.6,Moderate,11
rs753207473,FIG4,Amyotrophic lateral sclerosis type 11 (ALS11),single nucleotide variant,nonsense,6,109716541,R88*,Pathogenic,C,T,rs753207473,109716541.0,FIG4,6,ALS11_Classical,Adult,40-70 years,Moderate,0.7,Phosphoinositide metabolism,6.0,0.0002315867302775558,0.0003213715603656677,0.00021193281312253495,0.00022076072212183048,0.00018299190058308383,0.00022087665519466204,9.2,Severe,8
rs2486126464,FIG4,Amyotrophic lateral sclerosis type 11 (ALS11),Duplication,splice acceptor variant,6,109738323 - 109738324,,Likely pathogenic,-,G,rs2486126464,109738323.0,FIG4,6,ALS11_Classical,Adult,40-70 years,Moderate,0.7,Phosphoinositide metabolism,6.0,0.00010067005594617908,0.00013544519035410839,0.00010797290635454962,8.223327684903484e-05,9.312719176472228e-05,8.457171440848021e-05,7.8,Moderate,3
rs1583695322,FIG4,Amyotrophic lateral sclerosis type 11 (ALS11),Deletion,frameshift variant,6,109760259,R384fs,Likely pathogenic,N,-,rs1583695322,109760259.0,FIG4,6,ALS11_Classical,Adult,40-70 years,Moderate,0.7,Phosphoinositide metabolism,6.0,0.0007732106250147984,0.0009994319063962576,0.00042163358589261007,0.000884160699429382,0.0007580661944318088,0.0008027607389239337,8.4,Severe,24
6:109760262,FIG4,Amyotrophic lateral sclerosis type 11 (ALS11),single nucleotide variant,nonsense,6,109760262,R384*,Likely pathogenic,A,T,6:109760262,109760262.0,FIG4,6,ALS11_Classical,Adult,40-70 years,Moderate,0.7,Phosphoinositide metabolism,6.0,0.00030294459103555603,0.00027228940208844505,0.0003859685262125382,0.00028246313628441273,0.00034350337142276466,0.00023049851916961966,8.4,Severe,9
6:109763935,FIG4,Amyotrophic lateral sclerosis type 11 (ALS11),single nucleotide variant,splice acceptor variant,6,109763935,,Likely pathogenic,A,G,6:109763935,109763935.0,FIG4,6,ALS11_Classical,Adult,40-70 years,Moderate,0.7,Phosphoinositide metabolism,6.0,0.0008969874425456542,0.0012635053699765928,0.0010024521889060625,0.0006550915949567975,0.0010829942301743072,0.00048089382871451165,7.8,Moderate,40
rs756308787,FIG4,Amyotrophic lateral sclerosis type 11 (ALS11),single nucleotide variant,splice donor variant,6,109791573,,Likely pathogenic,T,G,rs756308787,109791573.0,FIG4,6,ALS11_Classical,Adult,40-70 years,Moderate,0.7,Phosphoinositide metabolism,6.0,4.995591574475679e-05,7.032387036217454e-05,6.341611896061782e-05,4.336822890776357e-05,4.3387579689266156e-05,2.928378080396181e-05,7.8,Moderate,2
rs2076486420,SYNE1,"Amyotrophic lateral sclerosis, unspecified type",single nucleotide variant,nonsense,6,152206257,"Q7573*, Q7644*",Pathogenic,C,T,rs2076486420,152206257.0,SYNE1,6,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.000403984211108472,0.0005827924456571725,0.00031919356438619794,0.00040225192057462056,0.0003694035672542936,0.0003462795576700752,9.2,Severe,7
rs2128109836,HNRNPA2B1,"Amyotrophic lateral sclerosis, unspecified type",single nucleotide variant,missense variant,7,26193322,"P310L, P298L",Likely pathogenic,C,T,rs2128109836,26193322.0,HNRNPA2B1,7,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.001501847264443423,0.0016746083819978296,0.0007904505684612721,0.0018157051775815733,0.001764582810714715,0.0014638893834617252,6.0,Moderate,37
9:27573529 - 27573534,C9orf72|LOC109504728|LOC129929032,Amyotrophic lateral sclerosis-frontotemporal dementia (C9orf72),Microsatellite,,9,27573529 - 27573534,,Pathogenic,,,9:27573529 - 27573534,27573529.0,C9orf72,9,ALS_FTD,Adult,50-65 years,Variable,0.82,Most common genetic cause; 40% of familial ALS; hexanucleotide repeat,8.0,0.0009023300630025075,0.0008389378995447232,0.0006787182067732805,0.0007269469995718428,0.0009412699988795303,0.001325777210243161,8.8,Severe,28
rs1554707622,SIGMAR1,Amyotrophic lateral sclerosis type 16 (ALS16) - Juvenile,Deletion,splice acceptor variant,9,34635592 - 34635883,,Likely pathogenic,N,-,rs1554707622,34635592.0,SIGMAR1,9,ALS16_Juvenile,Juvenile,1-10 years,Slow,0.52,Very early onset possible; ER stress response,5.0,0.0004070050834723402,0.0005798892765013244,0.0004802569403595095,0.00027912105693010843,0.00022196270750512884,0.0004737954360656299,6.5,Moderate,7
9:34635632,SIGMAR1,Amyotrophic lateral sclerosis type 16 (ALS16) - Juvenile,single nucleotide variant,missense variant|stop lost|3 prime UTR variant|non-coding transcript variant,9,34635632,T152A,Likely pathogenic,A,G,9:34635632,34635632.0,SIGMAR1,9,ALS16_Juvenile,Juvenile,1-10 years,Slow,0.52,Very early onset possible; ER stress response,5.0,0.0009529809640817004,0.0014530528145660548,0.0010541700129978633,0.0004816394716461656,0.0007060557104067223,0.001069986810791696,6.0,Moderate,29
rs2132323906,SIGMAR1,Amyotrophic lateral sclerosis type 16 (ALS16) - Juvenile,single nucleotide variant,missense variant|3 prime UTR variant|non-coding transcript variant|intron variant,9,34635667,"E113K, E182K, E193K, E213K",Likely pathogenic,G,A,rs2132323906,34635667.0,SIGMAR1,9,ALS16_Juvenile,Juvenile,1-10 years,Slow,0.52,Very early onset possible; ER stress response,5.0,0.0010078791607419188,0.0012509939868090866,0.00126959972426494,0.0004568173546767651,0.0010051953713156544,0.001056789366643148,5.0,Mild,27
rs1242817438,SIGMAR1,Amyotrophic lateral sclerosis type 16 (ALS16) - Juvenile,single nucleotide variant,nonsense|3 prime UTR variant|non-coding transcript variant|intron variant,9,34635812,"W133*, W144*, W164*, W64*",Pathogenic,G,A,rs1242817438,34635812.0,SIGMAR1,9,ALS16_Juvenile,Juvenile,1-10 years,Slow,0.52,Very early onset possible; ER stress response,5.0,0.0005576660910624837,0.0005980639749543587,0.0003920354161054873,0.0006454871014809162,0.0005233956667775256,0.0006293482959941304,7.7,Moderate,14
rs2492811707,SIGMAR1,Amyotrophic lateral sclerosis type 16 (ALS16) - Juvenile,Deletion,frameshift variant|non-coding transcript variant|intron variant,9,34635833 - 34635848,"V153fs, V122fs, V133fs, V53fs, S106fs",Pathogenic,N,-,rs2492811707,34635833.0,SIGMAR1,9,ALS16_Juvenile,Juvenile,1-10 years,Slow,0.52,Very early onset possible; ER stress response,5.0,0.0001683904534227429,0.00024512740533463693,8.554377766766215e-05,0.0002004498774279914,0.00016573114381833844,0.0001451000628650857,7.7,Moderate,7
rs1820836522,SIGMAR1,Amyotrophic lateral sclerosis type 16 (ALS16) - Juvenile,single nucleotide variant,missense variant|synonymous variant|non-coding transcript variant|intron variant,9,34635853,"T51A, D104G, T151A, T120A, T131A",Likely pathogenic,A,G,rs1820836522,34635853.0,SIGMAR1,9,ALS16_Juvenile,Juvenile,1-10 years,Slow,0.52,Very early onset possible; ER stress response,5.0,0.0011516816942687613,0.0008770878849974262,0.0014647869714994935,0.0007786271546428988,0.0016934765833597702,0.0009444298768442181,5.0,Mild,27
9:34636996,SIGMAR1,Amyotrophic lateral sclerosis type 16 (ALS16) - Juvenile,single nucleotide variant,splice donor variant|intron variant,9,34636996,,Pathogenic,G,A,9:34636996,34636996.0,SIGMAR1,9,ALS16_Juvenile,Juvenile,1-10 years,Slow,0.52,Very early onset possible; ER stress response,5.0,0.00010207143361802679,0.00014130902596024448,0.00012472918250920956,0.0001104827792110267,6.638931897595854e-05,6.744686143369463e-05,7.2,Moderate,5
9:34637039,SIGMAR1,Amyotrophic lateral sclerosis type 16 (ALS16) - Juvenile,single nucleotide variant,nonsense|synonymous variant|non-coding transcript variant|intron variant,9,34637039,"Q115*, Q135*, Q35*",Pathogenic,C,T,9:34637039,34637039.0,SIGMAR1,9,ALS16_Juvenile,Juvenile,1-10 years,Slow,0.52,Very early onset possible; ER stress response,5.0,0.00010575556858879473,0.00012986951186831153,6.611383748652594e-05,0.00013513092758556542,0.00012488193929758277,7.278162670598797e-05,7.7,Moderate,3
rs755994483,SIGMAR1,Amyotrophic lateral sclerosis type 16 (ALS16) - Juvenile,single nucleotide variant,nonsense|synonymous variant|non-coding transcript variant|intron variant,9,34637068,"S105*, S125*, S25*",Pathogenic,C,A,rs755994483,34637068.0,SIGMAR1,9,ALS16_Juvenile,Juvenile,1-10 years,Slow,0.52,Very early onset possible; ER stress response,5.0,0.0004983552797192168,0.0005600412831688179,0.00038079228957498955,0.0005313680642355918,0.0004522365949509314,0.0005673381666657534,7.7,Moderate,14
9:34637352 - 34637355,SIGMAR1,Amyotrophic lateral sclerosis type 16 (ALS16) - Juvenile,Deletion,frameshift variant|5 prime UTR variant|non-coding transcript variant,9,34637352 - 34637355,"V53fs, V73fs",Pathogenic,N,-,9:34637352 - 34637355,34637352.0,SIGMAR1,9,ALS16_Juvenile,Juvenile,1-10 years,Slow,0.52,Very early onset possible; ER stress response,5.0,0.0002904393333631876,0.00022998407719058766,0.00040047897069142867,0.00041764724687916755,0.00018710331099162114,0.0002169830610631331,7.7,Moderate,14
rs2132329744,SIGMAR1,Amyotrophic lateral sclerosis type 16 (ALS16) - Juvenile,single nucleotide variant,splice acceptor variant,9,34637422,,Likely pathogenic,A,T,rs2132329744,34637422.0,SIGMAR1,9,ALS16_Juvenile,Juvenile,1-10 years,Slow,0.52,Very early onset possible; ER stress response,5.0,0.0009736885964330654,0.0013972254666573874,0.0008185413074283674,0.0007441350385658604,0.0010265998890805906,0.0008819412804331211,6.5,Moderate,21
rs2492828821,LOC130001681|SIGMAR1,"Amyotrophic lateral sclerosis, unspecified type",Deletion,frameshift variant|5 prime UTR variant|non-coding transcript variant|intron variant,9,34637572 - 34637573,I42fs,Pathogenic,N,-,rs2492828821,34637572.0,LOC130001681,9,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.0006511411100905744,0.0008588602948990633,0.0007738623575896157,0.0006283021241711822,0.0003848737846093721,0.0006098069891836383,9.2,Severe,22
9:34637588 - 34637589,SIGMAR1|LOC130001681,Amyotrophic lateral sclerosis type 16 (ALS16) - Juvenile,Deletion,frameshift variant|5 prime UTR variant|non-coding transcript variant|intron variant,9,34637588 - 34637589,F37fs,Likely pathogenic,N,-,9:34637588 - 34637589,34637588.0,SIGMAR1,9,ALS16_Juvenile,Juvenile,1-10 years,Slow,0.52,Very early onset possible; ER stress response,5.0,0.0009211605581268247,0.0007881211497243692,0.0008543168497498232,0.0006672428914068994,0.0011005578840774018,0.0011955640156756302,7.0,Moderate,23
rs1449250083,LOC130001681|SIGMAR1,"Amyotrophic lateral sclerosis, unspecified type",single nucleotide variant,nonsense|5 prime UTR variant|non-coding transcript variant,9,34637612,W29*,Pathogenic,G,A,rs1449250083,34637612.0,LOC130001681,9,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.0005207759509245913,0.00044962230810238405,0.00047594175869865806,0.0006009603849206043,0.0004846687089641386,0.0005926865939371711,9.2,Severe,12
9:34637625,LOC130001681|SIGMAR1,"Amyotrophic lateral sclerosis, unspecified type",Deletion,frameshift variant|5 prime UTR variant|non-coding transcript variant,9,34637625,V25fs,Likely pathogenic,N,-,9:34637625,34637625.0,LOC130001681,9,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.0009565840292746491,0.0012382484945576186,0.001000431035902226,0.000889749909095821,0.0009425121559891633,0.0007119785508284172,8.4,Severe,33
rs1564096761,LOC130001681|SIGMAR1,"Amyotrophic lateral sclerosis, unspecified type",Deletion,frameshift variant|5 prime UTR variant|non-coding transcript variant,9,34637685,V5fs,Pathogenic,N,-,rs1564096761,34637685.0,LOC130001681,9,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.0004545846054517065,0.0005639471161909013,0.00039689928497741117,0.00046939225702731795,0.0003467574787288693,0.0004959268903340333,9.2,Severe,8
rs1828783140,VCP,Amyotrophic lateral sclerosis type 14 (ALS14) - Multisystem Proteinopathy,single nucleotide variant,missense variant,9,35064214,"I171M, I216M",Likely pathogenic,A,G,rs1828783140,35064214.0,VCP,9,ALS14_Multisystem,Adult,40-60 years,Moderate,0.75,"Part of multisystem proteinopathy; may include myopathy, Paget disease, FTD",7.0,0.0003246065312195179,0.0004050925241199987,0.00028146850496129033,0.0003198133110998161,0.0002909207878420946,0.00032573752807438965,7.0,Moderate,5
rs1828784075,VCP,Amyotrophic lateral sclerosis type 14 (ALS14) - Multisystem Proteinopathy,single nucleotide variant,splice acceptor variant,9,35064287,,Likely pathogenic,A,G,rs1828784075,35064287.0,VCP,9,ALS14_Multisystem,Adult,40-60 years,Moderate,0.75,"Part of multisystem proteinopathy; may include myopathy, Paget disease, FTD",7.0,0.00042128061394921715,0.0003611550942584907,0.0005173801180743921,0.0004210444753503349,0.00046712063057892644,0.00033970275148394164,9.1,Severe,9
9:35065264,VCP,Amyotrophic lateral sclerosis type 14 (ALS14) - Multisystem Proteinopathy,single nucleotide variant,missense variant,9,35065264,"P143H, P188H",Likely pathogenic,C,A,9:35065264,35065264.0,VCP,9,ALS14_Multisystem,Adult,40-60 years,Moderate,0.75,"Part of multisystem proteinopathy; may include myopathy, Paget disease, FTD",7.0,0.0011430740122276917,0.0012570426479702646,0.0012266198486146633,0.0007498214725083299,0.001469025464909338,0.001012860627135863,7.0,Moderate,39
rs1554668813,VCP,Amyotrophic lateral sclerosis type 14 (ALS14) - Multisystem Proteinopathy,single nucleotide variant,missense variant,9,35065355,"M158V, M113V",Pathogenic,A,G,rs1554668813,35065355.0,VCP,9,ALS14_Multisystem,Adult,40-60 years,Moderate,0.75,"Part of multisystem proteinopathy; may include myopathy, Paget disease, FTD",7.0,0.0004299916316025728,0.0004612773021427405,0.0004657040104233787,0.00021359137657236117,0.0004987497623145996,0.000510635706559784,7.7,Moderate,10
rs1554668814,VCP,Amyotrophic lateral sclerosis type 14 (ALS14) - Multisystem Proteinopathy,single nucleotide variant,missense variant,9,35065358,"G112R, G157R",Pathogenic,G,A,rs1554668814,35065358.0,VCP,9,ALS14_Multisystem,Adult,40-60 years,Moderate,0.75,"Part of multisystem proteinopathy; may include myopathy, Paget disease, FTD",7.0,0.0003862639257752363,0.0004180728076192826,0.0005401762007291318,0.00017184904045918867,0.00031163275220632983,0.0004895888278622485,7.7,Moderate,9
rs121909330,VCP,Amyotrophic lateral sclerosis type 14 (ALS14) - Multisystem Proteinopathy,single nucleotide variant,missense variant,9,35065364,"R155S, R110S",Pathogenic,C,A,rs121909330,35065364.0,VCP,9,ALS14_Multisystem,Adult,40-60 years,Moderate,0.75,"Part of multisystem proteinopathy; may include myopathy, Paget disease, FTD",7.0,0.0006824048470589802,0.0009859179837829871,0.0007535873421250225,0.0003462605626648988,0.0008034062577430287,0.000522852088978964,7.7,Moderate,22
rs2490370338,VCP,Amyotrophic lateral sclerosis type 14 (ALS14) - Multisystem Proteinopathy,single nucleotide variant,missense variant,9,35066738,"G83S, G128S",Likely pathogenic,G,A,rs2490370338,35066738.0,VCP,9,ALS14_Multisystem,Adult,40-60 years,Moderate,0.75,"Part of multisystem proteinopathy; may include myopathy, Paget disease, FTD",7.0,0.0011689481582993217,0.0009661629939103378,0.0009051551043381603,0.0016767241669915617,0.0008865453897777101,0.0014101531364788384,7.0,Moderate,30
rs1828864269,VCP,Amyotrophic lateral sclerosis type 14 (ALS14) - Multisystem Proteinopathy,single nucleotide variant,missense variant,9,35067899,"D53E, D98E",Likely pathogenic,T,A,rs1828864269,35067899.0,VCP,9,ALS14_Multisystem,Adult,40-60 years,Moderate,0.75,"Part of multisystem proteinopathy; may include myopathy, Paget disease, FTD",7.0,0.0021307523575912974,0.002616888909773885,0.0014818401953232828,0.0013848901187998846,0.002671724408543984,0.002498418155515452,7.0,Moderate,72
rs864309502,VCP,Amyotrophic lateral sclerosis type 14 (ALS14) - Multisystem Proteinopathy,single nucleotide variant,missense variant,9,35067903,"G97E, G52E",Pathogenic,G,A,rs864309502,35067903.0,VCP,9,ALS14_Multisystem,Adult,40-60 years,Moderate,0.75,"Part of multisystem proteinopathy; may include myopathy, Paget disease, FTD",7.0,0.0013132479199702775,0.001534901650940814,0.0015613818682318262,0.0014149169330055125,0.0008521601661374868,0.0012028789815357484,7.7,Moderate,40
rs758169026,VCP,Amyotrophic lateral sclerosis type 14 (ALS14) - Multisystem Proteinopathy,single nucleotide variant,missense variant,9,35067909,"R50H, R95H",Likely pathogenic,G,A,rs758169026,35067909.0,VCP,9,ALS14_Multisystem,Adult,40-60 years,Moderate,0.75,"Part of multisystem proteinopathy; may include myopathy, Paget disease, FTD",7.0,0.002161656463448435,0.001869589201132033,0.0014915212463846939,0.0019948465741953005,0.00280033856121354,0.002651986734316608,7.0,Moderate,67
rs121909332,VCP,Amyotrophic lateral sclerosis type 14 (ALS14) - Multisystem Proteinopathy,single nucleotide variant,missense variant,9,35067910,"R50S, R95S",Likely pathogenic,C,A,rs121909332,35067910.0,VCP,9,ALS14_Multisystem,Adult,40-60 years,Moderate,0.75,"Part of multisystem proteinopathy; may include myopathy, Paget disease, FTD",7.0,0.0009120632501460051,0.000888502652568392,0.0006993213389401755,0.0010618674691340363,0.0010321392631302208,0.0008784855269572005,7.0,Moderate,21
rs121909332,VCP,Amyotrophic lateral sclerosis type 14 (ALS14) - Multisystem Proteinopathy,single nucleotide variant,missense variant,9,35067910,"R95G, R50G",Pathogenic,C,G,rs121909332,35067910.0,VCP,9,ALS14_Multisystem,Adult,40-60 years,Moderate,0.75,"Part of multisystem proteinopathy; may include myopathy, Paget disease, FTD",7.0,0.0012308853104429703,0.0012848013424252994,0.0014764521337371915,0.0008757534213558546,0.0012095674409740658,0.0013078522137224395,7.7,Moderate,30
rs1563980966,VCP,Amyotrophic lateral sclerosis type 14 (ALS14) - Multisystem Proteinopathy,single nucleotide variant,missense variant,9,35067920,"N46K, N91K",Likely pathogenic,C,A,rs1563980966,35067920.0,VCP,9,ALS14_Multisystem,Adult,40-60 years,Moderate,0.75,"Part of multisystem proteinopathy; may include myopathy, Paget disease, FTD",7.0,0.0015643667954933099,0.0016760069424278858,0.001726012934297829,0.0016681539620491694,0.0015179969631611188,0.001233663175530547,7.0,Moderate,36
rs1563980966,VCP,Amyotrophic lateral sclerosis type 14 (ALS14) - Multisystem Proteinopathy,single nucleotide variant,missense variant,9,35067920,"N46K, N91K",Likely pathogenic,C,G,rs1563980966,35067920.0,VCP,9,ALS14_Multisystem,Adult,40-60 years,Moderate,0.75,"Part of multisystem proteinopathy; may include myopathy, Paget disease, FTD",7.0,0.0008212015601146135,0.0006829865406596301,0.0008725249865181234,0.0009833925375333694,0.0007536304337459902,0.0008134733021159544,7.0,Moderate,21
rs863225291,VCP,Amyotrophic lateral sclerosis type 14 (ALS14) - Multisystem Proteinopathy,single nucleotide variant,missense variant,9,35067922,"N91Y, N46Y",Pathogenic,A,T,rs863225291,35067922.0,VCP,9,ALS14_Multisystem,Adult,40-60 years,Moderate,0.75,"Part of multisystem proteinopathy; may include myopathy, Paget disease, FTD",7.0,0.000300784966645186,0.00032869003353129425,0.00020446361613778781,0.0003435791329303796,0.0004670537831263454,0.0001601382675001231,7.7,Moderate,8
rs900105227,VCP,Amyotrophic lateral sclerosis type 14 (ALS14) - Multisystem Proteinopathy,single nucleotide variant,missense variant,9,35067927,"R44Q, R89Q",Pathogenic,G,A,rs900105227,35067927.0,VCP,9,ALS14_Multisystem,Adult,40-60 years,Moderate,0.75,"Part of multisystem proteinopathy; may include myopathy, Paget disease, FTD",7.0,0.0007074743400821858,0.000819321044068392,0.0006744865834826824,0.00040945851075224765,0.000713835058239037,0.0009202705038685699,7.7,Moderate,18
rs2118840030,SPTLC1,"Amyotrophic lateral sclerosis, unspecified type",Deletion,inframe_deletion|5 prime UTR variant,9,92112497 - 92112502,,Likely pathogenic,N,-,rs2118840030,92112497.0,SPTLC1,9,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.002118493367117982,0.0021581823801830784,0.0023521920135857848,0.0017909164352358515,0.0023505753156264375,0.0019406006909587585,6.9,Moderate,62
9:132271758,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,Deletion,frameshift variant,9,132271758,C2384fs,Pathogenic,N,-,9:132271758,132271758.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.00010597105097617018,0.00013788885800559988,6.959471585644469e-05,9.211690704241298e-05,0.00011180784605546855,0.00011844692792092476,6.2,Moderate,1
rs1554804809,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,single nucleotide variant,splice donor variant,9,132275254,,Likely pathogenic,T,C,rs1554804809,132275254.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.000253108777986776,0.00037182191516000685,0.00022609294096282215,0.00018623698303091697,0.0003233928387720303,0.00015799921200810376,5.2,Mild,7
rs1186690391,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,Deletion,splice acceptor variant,9,132277153 - 132277155,,Likely pathogenic,N,-,rs1186690391,132277153.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.0009044962799521193,0.0011120549014309415,0.0004673631170430525,0.0007654291527212583,0.0010570849839252933,0.001120549244640051,5.2,Mild,26
rs1038776365,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,single nucleotide variant,splice donor variant,9,132278069,,Likely pathogenic,G,T,rs1038776365,132278069.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.0009179164369303501,0.0013344005657016187,0.0008778981574789159,0.0008599289843770346,0.0008680050030087714,0.0006493494740854101,5.2,Mild,21
9:132283388 - 132283389,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,Duplication,frameshift variant,9,132283388 - 132283389,Q2141fs,Pathogenic,N,NN,9:132283388 - 132283389,132283388.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.0003223710027986734,0.0004065022950761513,0.0003174212047627609,0.00017197265305259835,0.000397610330653145,0.0003183485304487116,6.2,Moderate,9
rs2538904662,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,Microsatellite,frameshift variant,9,132283388 - 132283389,Q2141fs,Pathogenic,N,-,rs2538904662,132283388.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.000769126376794945,0.00047682026962008513,0.0005745043479460825,0.0007618475188997626,0.0009951572979087662,0.001037302449600029,6.2,Moderate,27
rs1844047388,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,single nucleotide variant,nonsense,9,132288292,Q2090*,Pathogenic,C,T,rs1844047388,132288292.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.000866675719667735,0.0007522356639843166,0.00083007132415747,0.0009463817618359106,0.0009701209926090419,0.0008345688557519356,6.2,Moderate,27
rs754618817,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,Duplication,splice donor variant,9,132288547 - 132288548,,Likely pathogenic,N,NN,rs754618817,132288547.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.0003663165723858194,0.0004172082019829763,0.0004618712875788863,0.00030662522494676655,0.00043394979649980105,0.00021192835092066653,5.2,Mild,12
9:132296894,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,single nucleotide variant,missense variant,9,132296894,L1981R,Pathogenic,T,G,9:132296894,132296894.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.0007780280114173975,0.0008238891278327607,0.0007777414789835414,0.000831001927999979,0.0007890560774903522,0.0006684514447803535,4.4,Mild,17
rs776632212,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,Deletion,frameshift variant,9,132326334,T1755fs,Pathogenic,N,-,rs776632212,132326334.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.0006538921249380512,0.0008864301770692193,0.000585455926990203,0.00036856782024260456,0.0006779231867565092,0.0007510835136317201,6.2,Moderate,18
rs2539088969,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,Deletion,frameshift variant,9,132326579,V1674fs,Pathogenic,N,-,rs2539088969,132326579.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.00016784399503189343,0.00015040461996040835,0.00018539429608864456,0.0001314316369922201,0.00022280770998452852,0.00014918171213366572,6.2,Moderate,1
rs757883779,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,Duplication,frameshift variant,9,132326707 - 132326708,I1631fs,Pathogenic,N,NN,rs757883779,132326707.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.000502739334981233,0.0006684548381116282,0.0004615136236670185,0.0004669809410311285,0.00026737442084069223,0.0006493728512556971,6.2,Moderate,14
rs746973259,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,Duplication,frameshift variant,9,132326918 - 132326919,N1560fs,Pathogenic,N,NN,rs746973259,132326918.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.0004461153474692044,0.00038413391043174024,0.0004069590293586898,0.000508681104677871,0.0005113969429525968,0.0004194057499251244,6.2,Moderate,12
rs2131440608,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,single nucleotide variant,nonsense,9,132327917,C1227*,Pathogenic,T,A,rs2131440608,132327917.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.0003378392760399228,0.0003785901068532389,0.00033918125193580905,0.0002655071846946887,0.00033286719488168683,0.00037305064183419044,6.2,Moderate,13
rs1846980272,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,Deletion,frameshift variant,9,132328307 - 132328310,H1096fs,Pathogenic,N,-,rs1846980272,132328307.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.0003844281214247525,0.0004212353060653894,0.0005584809384423797,0.0002170608563653657,0.0005390079931382118,0.00018635551311241576,6.2,Moderate,8
9:132328385 - 132328386,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,Deletion,frameshift variant,9,132328385 - 132328386,F1071fs,Pathogenic,N,-,9:132328385 - 132328386,132328385.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.00011763129921152433,0.00012545897949175537,0.000139713537265019,5.345035086129274e-05,0.00018152885795133162,8.800477048822301e-05,6.2,Moderate,7
9:132328610 - 132328611,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,Deletion,frameshift variant,9,132328610 - 132328611,R996fs,Pathogenic,N,-,9:132328610 - 132328611,132328610.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.0005418334590170069,0.0005875040764537545,0.0006136127740176856,0.00034951236782113326,0.0006617477127197751,0.000496790364072686,6.2,Moderate,16
rs2131461009,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,single nucleotide variant,missense variant,9,132330114,L495P,Pathogenic,T,C,rs2131461009,132330114.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.0005227068355512949,0.000648953263193011,0.000520306654884742,0.00041357816420263787,0.0006527764462260168,0.0003779196492500666,4.4,Mild,20
rs2131463306,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,single nucleotide variant,missense variant,9,132330431,L389F,Likely pathogenic,A,C,rs2131463306,132330431.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.0012694746613782807,0.0012148996539578024,0.0007431105063842405,0.0016389230429677889,0.0011871115533062947,0.0015633285502752768,4.0,Mild,34
rs2131463325,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,Deletion,inframe_deletion,9,132330431 - 132330433,L389del,Likely pathogenic,N,-,rs2131463325,132330431.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.0005384548474205652,0.0006324554927571263,0.00048171078946263106,0.0005033565787657952,0.0006869989756671164,0.00038775240045015746,4.6,Mild,19
rs2131463657,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,single nucleotide variant,nonsense,9,132330488,W370*,Likely pathogenic,G,A,rs2131463657,132330488.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.0005179089086300834,0.0007327060255131184,0.0003289241984567784,0.0005449901339264598,0.0005250502188051324,0.00045787396644892737,5.6,Mild,20
rs2539140886,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,single nucleotide variant,splice acceptor variant,9,132331141,,Likely pathogenic,A,G,rs2539140886,132331141.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.0007131775088678919,0.0007345098147083045,0.0006519624768008871,0.0006111819928610278,0.000758126854546957,0.000810106405422283,5.2,Mild,20
rs2539238128,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,Deletion,splice donor variant,9,132346259 - 132346262,,Pathogenic,N,-,rs2539238128,132346259.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.000533718650859373,0.00044983988366882507,0.0006780788572341541,0.0005883746850613529,0.0003283324496280565,0.0006239673787044761,5.7,Mild,13
rs587776537,SETX,Amyotrophic lateral sclerosis type 4 (ALS4) - Juvenile,Microsatellite,inframe_deletion,9,132346304 - 132346306,L115del,Likely pathogenic,N,-,rs587776537,132346304.0,SETX,9,ALS4_Juvenile,Juvenile,<25 years,Slow,0.5,Slow progression; normal lifespan possible; distal predominant,4.0,0.0005847348941295165,0.0006475868368640234,0.000918106183219702,0.000386900623350362,0.00034529315600275313,0.0006257876712107415,4.6,Mild,19
10:13109103 - 13136886,LOC130003372|OPTN|LOC108903148|LOC108903149,"Amyotrophic lateral sclerosis, unspecified type",Deletion,,10,13109103 - 13136886,,Pathogenic,N,-,10:13109103 - 13136886,13109103.0,LOC130003372,10,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.00019928564775596288,0.0001733877608609288,0.00016827486453193272,0.00015960947973635745,0.00029930825223584937,0.00019584788141474604,6.6,Moderate,5
10:13109123 - 13183100,LOC108903148|LOC108903149|LOC121366042|LOC130003372|LOC130003373|MCM10|OPTN,"Amyotrophic lateral sclerosis, unspecified type",Deletion,,10,13109123 - 13183100,,Pathogenic,N,-,10:13109123 - 13183100,13109123.0,LOC108903148,10,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.0004940557891301667,0.0005455771873817782,0.0004305690309009507,0.0005047857184463737,0.0006842489260235486,0.0003050980828981818,6.6,Moderate,16
10:13109279,LOC108903148|OPTN,"Amyotrophic lateral sclerosis, unspecified type",single nucleotide variant,nonsense,10,13109279,Q53*,Pathogenic,C,T,10:13109279,13109279.0,LOC108903148,10,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.0004130243090165606,0.0004489948934436655,0.00040968408608020655,0.0004532040303029819,0.00032233895148942656,0.0004308995837665228,9.2,Severe,14
rs1564354968,LOC108903148|OPTN,"Amyotrophic lateral sclerosis, unspecified type",Duplication,frameshift variant,10,13109279 - 13109280,K55fs,Pathogenic,N,NN,rs1564354968,13109279.0,LOC108903148,10,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.00033585958040279265,0.00038077534132010784,0.0003472472259780008,0.0002767444048306033,0.0004411519828377849,0.00023337894704746634,9.2,Severe,8
rs1359892832,LOC108903148|OPTN,"Amyotrophic lateral sclerosis, unspecified type",single nucleotide variant,nonsense,10,13110348,E81*,Pathogenic,G,T,rs1359892832,13110348.0,LOC108903148,10,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.00032026639420321986,0.00037228537207749385,0.00029370673040071644,0.0003263110636165212,0.00044325816426020134,0.00016577064066116638,9.2,Severe,8
10:13110436 - 13110437,LOC108903148|OPTN,"Amyotrophic lateral sclerosis, unspecified type",Duplication,frameshift variant,10,13110436 - 13110437,G112fs,Pathogenic,N,NN,10:13110436 - 13110437,13110436.0,LOC108903148,10,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.00039523586256014307,0.000462867453070785,0.0002965601327655778,0.0002848967121875376,0.0005966072411152366,0.0003352477736615783,9.2,Severe,14
rs113349726,LOC108903148|OPTN,"Amyotrophic lateral sclerosis, unspecified type",single nucleotide variant,splice donor variant,10,13110478,,Likely pathogenic,T,C,rs113349726,13110478.0,LOC108903148,10,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.0005608004653341917,0.0008913728790797739,0.0007523362829771949,0.00029173058618131424,0.00031486193523540024,0.000553700643197275,7.8,Moderate,22
rs2131488754,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),single nucleotide variant,splice acceptor variant,10,13112452,,Likely pathogenic,G,A,rs2131488754,13112452.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.0008337530199301396,0.0012126159853739918,0.0006554908436275203,0.0007570745982381781,0.0008988464100555354,0.0006447372623554721,7.8,Moderate,29
rs140599944,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),single nucleotide variant,nonsense,10,13112486,E135*,Pathogenic,G,T,rs140599944,13112486.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.00035900031052008225,0.00046749377344357495,0.0002573758277438821,0.000308939331951871,0.0003643224804394395,0.0003968701390216436,9.2,Severe,13
rs2539041527,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),Insertion,frameshift variant,10,13112502 - 13112503,K140fs,Pathogenic,-,TC,rs2539041527,13112502.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.0001472502438911276,0.0001551283579040719,0.0001563200062802604,0.00010749199718934742,0.00017797006280546415,0.0001393407952764941,9.2,Severe,7
rs2131488944,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),single nucleotide variant,nonsense,10,13112519,Q146*,Likely pathogenic,C,T,rs2131488944,13112519.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.0009339769632318274,0.0011736512317036454,0.0008906417988678099,0.0009795687661536732,0.0007944728453284926,0.0008315501741055156,8.4,Severe,30
rs1283443715,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),Duplication,frameshift variant,10,13112532 - 13112533,Q151fs,Pathogenic,N,NN,rs1283443715,13112532.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.0004956689340294732,0.0006484641510697342,0.00035156005940300633,0.00044233286968564086,0.0007012531164005222,0.00033473447358846244,9.2,Severe,21
rs771268520,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),Deletion,frameshift variant,10,13112606,E175fs,Pathogenic,N,-,rs771268520,13112606.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.00039338598995862246,0.0004348154282791646,0.0004396916776204175,0.0002030234108238972,0.0004371599503327473,0.00045223948273688557,9.2,Severe,13
rs1328890259,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),single nucleotide variant,nonsense,10,13118910,R217*,Pathogenic,A,T,rs1328890259,13118910.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.0006797652577607137,0.0010664472438803537,0.0004970877037698689,0.0005693892810436472,0.000568051211132827,0.0006978508489768721,9.2,Severe,19
rs2539056279,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),Deletion,frameshift variant,10,13118926,K223fs,Pathogenic,N,-,rs2539056279,13118926.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.0004492311940993165,0.0003352882376436956,0.00039325996622353334,0.0004231505855405466,0.0006976820433000841,0.0003967751377887229,9.2,Severe,10
rs757559365,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),Microsatellite,,10,13122383 - 13122384,,Pathogenic,,,rs757559365,13122383.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.0008077867912512505,0.001146716455208023,0.000469093501662387,0.0008016628598557265,0.0008214277859409635,0.0008000333535891523,6.6,Moderate,26
rs759311192,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),single nucleotide variant,splice acceptor variant,10,13122384,,Likely pathogenic,G,C,rs759311192,13122384.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,8.295757230138429e-05,8.844905096825917e-05,0.00013536018437516355,6.46964148546593e-05,6.360993322497547e-05,6.2672278083864e-05,7.8,Moderate,5
rs1833371664,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),Duplication,frameshift variant,10,13122477 - 13122478,E293fs,Likely pathogenic,N,NN,rs1833371664,13122477.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.00047967920637001624,0.0006536841812307564,0.0006164795626473028,0.00038809744406740785,0.0004173003182385699,0.0003228345256660444,8.4,Severe,18
rs2539062305,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),Microsatellite,splice donor variant,10,13122487 - 13122488,,Likely pathogenic,N,-,rs2539062305,13122487.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.00044771168040934177,0.0004564628998355272,0.0006490883965475122,0.0003456497548128899,0.0004796572901749119,0.0003077000606758673,7.8,Moderate,16
10:13124028 - 13124038,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),Deletion,frameshift variant,10,13124028 - 13124038,,Likely pathogenic,N,-,10:13124028 - 13124038,13124028.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.0009840103168418004,0.0015708393454452226,0.0012188455491015395,0.0007075747968465286,0.0005512772686184082,0.0008715146241973035,8.4,Severe,35
rs778911925,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),Deletion,frameshift variant,10,13124098 - 13124102,R329fs,Pathogenic,N,-,rs778911925,13124098.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,8.5280499466562e-05,0.00013900428144603903,0.00011046421970848255,3.8929865335157736e-05,5.296307746376211e-05,8.504105337936855e-05,9.2,Severe,2
rs746420444,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),single nucleotide variant,nonsense,10,13125422,Q335*,Pathogenic,C,T,rs746420444,13125422.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.0005951519147796307,0.0006429076029290246,0.0008045518149452468,0.000489733270775821,0.0007609920462411716,0.0002775748390068891,9.2,Severe,30
rs1564365123,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),Deletion,frameshift variant,10,13125522,M368fs,Pathogenic,N,-,rs1564365123,13125522.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.0005605391181982562,0.0007015981460261251,0.0004361478019956079,0.0005152914374229798,0.000478497699534297,0.000671160506012271,9.2,Severe,11
rs1833451208,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),Deletion,frameshift variant,10,13126014,T406fs,Pathogenic,N,-,rs1833451208,13126014.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.00016830383288232378,0.00017232558571316658,0.00012785143649212237,0.00015322776327900188,0.00017784223534820124,0.00021027214357912698,9.2,Severe,5
10:13126037,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),single nucleotide variant,nonsense,10,13126037,E414*,Pathogenic,G,T,10:13126037,13126037.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.0004971603473836664,0.0005683101597377043,0.0005502223220222012,0.00042508574786134264,0.00041640868391236294,0.0005257748233847209,9.2,Severe,14
10:13127785,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),Deletion,frameshift variant,10,13127785,K429fs,Pathogenic,N,-,10:13127785,13127785.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,7.838757367353917e-05,0.0001044346170795522,0.00010577354051755373,3.584286352914044e-05,3.9525992326832635e-05,0.00010636085491461682,9.2,Severe,2
rs1206423781,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),Deletion,frameshift variant,10,13127791 - 13127792,L430fs,Pathogenic,N,-,rs1206423781,13127791.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.0001023250673075664,0.00015842864451713918,8.968166110585199e-05,5.320050248470605e-05,8.340342254644983e-05,0.00012691110588368494,9.2,Severe,3
rs2539070896,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),Duplication,frameshift variant,10,13127819 - 13127820,D445fs,Pathogenic,N,NN,rs2539070896,13127819.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.00020113413364327478,0.00029489201676676007,0.00026709001271645077,0.0002014633375087118,0.00011702960888058715,0.00012519569234386424,9.2,Severe,6
rs2131520977,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),single nucleotide variant,missense variant,10,13127902,Q467P,Likely pathogenic,A,C,rs2131520977,13127902.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.0016569483969802123,0.0011852279733072651,0.0011283504770991887,0.0018343513740461616,0.002257738596721467,0.00187907356372698,6.0,Moderate,42
rs1370982012,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),single nucleotide variant,splice donor variant,10,13127904,,Likely pathogenic,G,A,rs1370982012,13127904.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.0007203495261557009,0.0008609391105480157,0.0007496327674301225,0.0005745510019099943,0.00100173874643492,0.0004148860044554522,7.8,Moderate,18
rs267606929,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),single nucleotide variant,missense variant,10,13132098,E478G,Pathogenic,A,G,rs267606929,13132098.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.0015712801394053388,0.002410356987922737,0.0013662738541805207,0.0008783371431924685,0.0016716906881050289,0.0015297420236259401,6.6,Moderate,56
rs780777015,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),single nucleotide variant,nonsense,10,13133521,Q518*,Pathogenic,C,T,rs780777015,13133521.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.0002189344705022174,0.00023258718413607978,0.00021393966521786513,0.00019421352337933644,0.0002213451096148813,0.00023258687016292437,9.2,Severe,9
rs1357375850,OPTN,Amyotrophic lateral sclerosis type 12 (ALS12),single nucleotide variant,missense variant,10,13136802,K557T,Likely pathogenic,A,C,rs1357375850,13136802.0,OPTN,10,ALS12_Classical,Adult,30-60 years,Moderate,0.7,May have relatively slower progression,6.0,0.0021367187600710826,0.0015782410020923703,0.0018975159727228886,0.0016711008188756479,0.002851403521398419,0.0026853324852660876,6.0,Moderate,59
10:80166889,ANXA11,Amyotrophic lateral sclerosis type 23 (ALS23),single nucleotide variant,splice donor variant,10,80166889,,Pathogenic,G,A,10:80166889,80166889.0,ANXA11,10,ALS23_Classical,Adult,50-70 years,Moderate,0.68,Recently identified; RNA granule transport,6.0,0.00025203346616607816,0.0003582420260170372,0.00019292157798793212,0.00029048103926284703,0.0002218931767714584,0.00019662951079111617,8.6,Severe,12
rs1844420892,ERLIN1,"Amyotrophic lateral sclerosis, unspecified type",single nucleotide variant,missense variant|non-coding transcript variant|intron variant,10,100178156,"V10A, V94A",Pathogenic,T,C,rs1844420892,100178156.0,ERLIN1,10,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.0005852923355324597,0.0006811851140245974,0.0006168732906947679,0.0005738846735910015,0.0007574593899162547,0.00029705920943567677,6.6,Moderate,17
rs781660354,PRPH|TROAP-AS1,"Amyotrophic lateral sclerosis, unspecified type",single nucleotide variant,non-coding transcript variant|splice acceptor variant,12,49296431,,Likely pathogenic,G,A,rs781660354,49296431.0,PRPH,12,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.0006429605359869477,0.0009028169248825888,0.000539650449216541,0.0004036894941709227,0.0005663791669503093,0.0008022666447143763,7.8,Moderate,10
12:49297147,LOC124629354|PRPH|TROAP-AS1,"Amyotrophic lateral sclerosis, unspecified type",single nucleotide variant,non-coding transcript variant|splice acceptor variant,12,49297147,,Likely pathogenic,G,A,12:49297147,49297147.0,LOC124629354,12,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.0009302589214590301,0.0011200053092626139,0.0006694728351352611,0.0008871845544695013,0.0010253530868220507,0.000949278821605723,7.8,Moderate,27
rs2498984328,LOC124629354|PRPH|TROAP-AS1,"Amyotrophic lateral sclerosis, unspecified type",single nucleotide variant,non-coding transcript variant|nonsense,12,49297196,Q307*,Likely pathogenic,C,T,rs2498984328,49297196.0,LOC124629354,12,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.0007265218154888349,0.0011807391666182959,0.0004519299419752022,0.0006068345125190393,0.0009687524758577871,0.00042435298047384975,8.4,Severe,20
rs1592173638,HNRNPA1,Amyotrophic lateral sclerosis type 20 (ALS20),single nucleotide variant,missense variant|non-coding transcript variant,12,54283922,"P288A, P340A",Likely pathogenic,C,G,rs1592173638,54283922.0,HNRNPA1,12,ALS20_Multisystem,Adult,40-70 years,Variable,0.68,Part of multisystem proteinopathy spectrum,6.0,0.001467868274584077,0.001072556689582675,0.0012457552334079812,0.0008002362383075066,0.002171528287405339,0.0020492649242168834,6.0,Moderate,49
12:57572640,KIF5A,"Amyotrophic lateral sclerosis, unspecified type",single nucleotide variant,nonsense,12,57572640,"R455*, R544*",Pathogenic,C,T,12:57572640,57572640.0,KIF5A,12,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.000693651555811234,0.0009630552450971079,0.00041600596178928325,0.0007033230018791822,0.0007941252429882381,0.0005917483273023586,9.2,Severe,15
rs1402429085,KIF5A,"Amyotrophic lateral sclerosis, unspecified type",single nucleotide variant,intron variant,12,57582599,,Pathogenic,C,T,rs1402429085,57582599.0,KIF5A,12,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.0010225955950100222,0.0012809461302004336,0.0009497016680036489,0.0008951155754361978,0.0007001777412691116,0.0012870368601407194,6.6,Moderate,36
rs1555179091,KIF5A,"Amyotrophic lateral sclerosis, unspecified type",single nucleotide variant,splice donor variant,12,57582630,,Likely pathogenic,G,T,rs1555179091,57582630.0,KIF5A,12,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.0005302392902601316,0.0007658458235644247,0.00034649450148716585,0.00046264341766684306,0.0003292204393015344,0.0007469922692806903,7.8,Moderate,6
rs1555201919,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,nonsense,12,64455874,Q2*,Pathogenic,C,T,rs1555201919,64455874.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0007158812412347987,0.0007540983032713279,0.0008024611225451864,0.0007971133305030156,0.0008335221553424468,0.00039221129451201666,10.0,Severe,21
rs2539476696,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Indel,frameshift variant,12,64455938 - 64455940,V23fs,Likely pathogenic,N,-,rs2539476696,64455938.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0007071431514378971,0.0007127656933841747,0.0008921129041404472,0.0005210835072413295,0.0010085891947776192,0.0004011644576459145,9.8,Severe,18
rs1279619378,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Duplication,frameshift variant,12,64455939 - 64455940,R25fs,Pathogenic,N,NN,rs1279619378,64455939.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.00021274004371545319,0.0003709629606351193,0.00018541763979746206,0.0002032841839270823,0.00014501729438361676,0.00015901813983398548,10.0,Severe,4
rs1592350883,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Duplication,frameshift variant,12,64455954 - 64455955,K30fs,Pathogenic,N,NN,rs1592350883,64455954.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0005698636788233725,0.00048749230218406414,0.0006539287689983605,0.0006018056286581395,0.0005478255707663107,0.0005582661235099876,10.0,Severe,16
rs1592350887,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,synonymous variant,12,64455957,,Pathogenic,G,A,rs1592350887,64455957.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.00041464985131129024,0.0005589665875462425,0.0005001947995056913,0.0003016532505272758,0.00037158439709283783,0.0003408502218844035,7.7,Moderate,11
rs2539482429,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,nonsense,12,64460202,L34*,Pathogenic,T,G,rs2539482429,64460202.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0003347060660184254,0.0004541907217672784,0.00023126050873583686,0.00028860964798447836,0.00044469979535485197,0.00025476965624968156,10.0,Severe,13
12:64460284 - 64460287,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Deletion,frameshift variant,12,64460284 - 64460287,L62fs,Pathogenic,N,-,12:64460284 - 64460287,64460284.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0006058978483985389,0.0006574118564490365,0.00041643405942775816,0.0006975236595624722,0.0005709578678537861,0.0006871617986996421,10.0,Severe,21
12:64460307 - 64460310,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Deletion,frameshift variant,12,64460307 - 64460310,K69fs,Likely pathogenic,N,-,12:64460307 - 64460310,64460307.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0003149142321662307,0.00037407072630505625,0.00020678193085118008,0.00034047997344445393,0.00046987283959993523,0.00018336569063052808,9.8,Severe,6
12:64464386,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,missense variant,12,64464386,L94S,Likely pathogenic,T,C,12:64464386,64464386.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.000900335789386021,0.0014254015128016867,0.0008628315575724193,0.0005631796787756844,0.0008249508904268233,0.0008253153073534908,7.0,Moderate,34
rs2539489004,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Deletion,frameshift variant,12,64464405 - 64464414,S102fs,Pathogenic,N,-,rs2539489004,64464405.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,9.997916113502916e-05,0.00013211740771395074,0.00010044978078397376,7.520361732017713e-05,7.876820059517529e-05,0.00011335679926186888,10.0,Severe,2
rs200879808,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,missense variant,12,64464457,D118N,Likely pathogenic,G,A,rs200879808,64464457.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0006687076649992363,0.0008481854491889254,0.0007448932750952384,0.0007010226513606585,0.0006452015606249438,0.0004042353887264155,7.0,Moderate,23
rs1565814492,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Duplication,frameshift variant,12,64466962 - 64466963,I141fs,Pathogenic,N,NN,rs1565814492,64466962.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.00036347300451747917,0.0005209002820575258,0.00039128510185211193,0.0002845061014543039,0.0001898820905685151,0.00043079144665493925,10.0,Severe,10
rs1565814529,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Microsatellite,frameshift variant,12,64466995 - 64466996,Y153fs,Pathogenic,N,-,rs1565814529,64466995.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0002429248505371719,0.00041740561689438755,0.00015651816350754528,0.00018449123229717776,0.00019430167464874756,0.0002619075653380014,10.0,Severe,7
rs2539493394,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Deletion,frameshift variant,12,64467061,Y174fs,Pathogenic,N,-,rs2539493394,64467061.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,6.334109562119436e-05,9.13351878623612e-05,4.9845433848099754e-05,5.329494289717401e-05,5.2964996059850536e-05,6.926491743848626e-05,10.0,Severe,3
rs2539503647,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,splice donor variant,12,64474392,,Pathogenic,T,G,rs2539503647,64474392.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.00010003091949611884,0.00011933106887064434,8.856013641250247e-05,4.318476454072692e-05,0.00012496405135026104,0.00012411457630645943,10.0,Severe,6
rs2539510971,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Deletion,frameshift variant,12,64480030,K241fs,Pathogenic,N,-,rs2539510971,64480030.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0006605578504156293,0.0007874511970793057,0.000657175413528149,0.000639015167406171,0.000781313522184356,0.00043783395188016485,10.0,Severe,21
rs2539511024,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Microsatellite,frameshift variant,12,64480046 - 64480047,S247fs,Pathogenic,N,-,rs2539511024,64480046.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0006427707772339102,0.0008729666537876263,0.0004942687448066461,0.0006337847603043208,0.0006570246666300036,0.0005558090606409543,10.0,Severe,15
rs2539511036,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,nonsense,12,64480058,Q250*,Pathogenic,C,T,rs2539511036,64480058.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0006896004496738698,0.0010327528689158215,0.0004281282768002127,0.000816973236219506,0.00036055566505949167,0.0008095922013743172,10.0,Severe,20
12:64481918,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,nonsense,12,64481918,Q297*,Pathogenic,C,T,12:64481918,64481918.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,7.36843476355533e-05,8.601535649577303e-05,8.583744634183702e-05,5.48412388824082e-05,8.777597316858048e-05,5.3951723289167836e-05,10.0,Severe,1
12:64481963 - 64481964,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Duplication,frameshift variant,12,64481963 - 64481964,H312fs,Pathogenic,N,NN,12:64481963 - 64481964,64481963.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0008868466961443342,0.0011427294082828297,0.0008186367301335318,0.0009700216465009302,0.0007023709063810771,0.000800474789423302,10.0,Severe,31
rs369620088,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,nonsense,12,64481973,S315*,Pathogenic,C,A,rs369620088,64481973.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,4.1580526307456965e-05,5.950954499020036e-05,3.4955478146996626e-05,5.321456987980455e-05,2.300588967286056e-05,3.721714884742273e-05,10.0,Severe,1
rs758357594,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,missense variant,12,64484380,R357Q,Pathogenic,G,A,rs758357594,64484380.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0002961717542632644,0.0002821003377948305,0.00026842476814646854,0.00017668629072184006,0.00040588430930164665,0.00034776306535153615,7.7,Moderate,8
rs2136078402,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,splice donor variant,12,64484500,,Likely pathogenic,G,T,rs2136078402,64484500.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.00032168473950073645,0.00042633538787017675,0.00032528982809996223,0.0003475227536155817,0.0002583398140942929,0.00025093591382366874,9.1,Severe,17
rs2136078402,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,splice donor variant,12,64484500,,Likely pathogenic,G,A,rs2136078402,64484500.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.00013672702910460594,0.00019115513978746013,0.0001708650047925636,7.055789748005484e-05,8.99879928027871e-05,0.00016106911066016401,9.1,Severe,6
rs2539519111,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Deletion,frameshift variant,12,64485499,A412fs,Pathogenic,N,-,rs2539519111,64485499.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0005374525853186484,0.0004899449405096677,0.000702433858778057,0.0006190895964083775,0.0005506038553038254,0.0003251906755933143,10.0,Severe,15
rs2040816609,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Deletion,nonsense,12,64485949,,Pathogenic,N,-,rs2040816609,64485949.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.00039155494484135,0.0007547273005319181,0.000322107370724172,0.00021830238673884274,0.0003232203739641755,0.0003394172922476419,10.0,Severe,12
rs2539520026,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,nonsense,12,64485982,Y435*,Pathogenic,T,A,rs2539520026,64485982.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0004090572233993232,0.0004951881888182666,0.00046287742546086196,0.00041489660508575553,0.00032075280571500046,0.00035157109191673113,10.0,Severe,17
rs769588220,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,nonsense,12,64485995,"R440X, R440*",Pathogenic,C,T,rs769588220,64485995.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0005322299807428231,0.0005251483755368862,0.00037755933503024543,0.0006616108761561357,0.00041760716914883016,0.0006792241478420179,10.0,Severe,19
rs767898276,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,splice donor variant,12,64486018,,Pathogenic,G,A,rs767898276,64486018.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0003782096270164969,0.0004822375014129069,0.000415700926562011,0.00029235687684961057,0.00029973025007471176,0.00040102258018324407,10.0,Severe,8
rs1461457058,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,splice acceptor variant,12,64488486,,Likely pathogenic,G,C,rs1461457058,64488486.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0010137580938133178,0.0010641378627038458,0.0006448837031489779,0.0010017064033076555,0.0010794569168795557,0.001278605583026555,9.1,Severe,32
rs2539523784,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Deletion,frameshift variant,12,64488517 - 64488518,V458fs,Pathogenic,N,-,rs2539523784,64488517.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0006553206161176914,0.0004820354512091525,0.0006247573762965241,0.0006602416690027085,0.0010968856766415001,0.00041268290743857235,10.0,Severe,23
rs1178717934,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Duplication,frameshift variant,12,64488523 - 64488524,T462fs,Pathogenic,N,NN,rs1178717934,64488523.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.00044184620377951054,0.0006998238339777368,0.00045180322889056863,0.0003700452613408768,0.0003317309173954623,0.0003558277772929081,10.0,Severe,11
rs1476919390,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Deletion,frameshift variant,12,64488528 - 64488531,T462fs,Pathogenic,N,-,rs1476919390,64488528.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0007597315449852018,0.0009310370549488591,0.0006045219922993784,0.0008793233750736692,0.0007966185797381726,0.0005871567228659295,10.0,Severe,18
rs1555204731,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Deletion,frameshift variant,12,64488532 - 64488533,E463fs,Pathogenic,N,-,rs1555204731,64488532.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.00019627664329100554,0.0002702609253740555,0.00014710529347815247,8.571352074542715e-05,0.00026573133817193003,0.00021257213868546243,10.0,Severe,9
rs876657405,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Microsatellite,frameshift variant,12,64488580 - 64488581,V479fs,Likely pathogenic,N,-,rs876657405,64488580.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0003302813842236927,0.0003765650127220736,0.0002167262767160686,0.0002820541717535886,0.00040131292179250883,0.0003747485381342239,9.8,Severe,7
rs2539525878,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,splice acceptor variant,12,64490040,,Likely pathogenic,G,T,rs2539525878,64490040.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.000790439284563667,0.0007413159113671991,0.0005757957062664089,0.0011471952813916178,0.0008651132858036095,0.0006227762379894987,9.1,Severe,18
rs1280163869,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,nonsense,12,64490094,S499*,Pathogenic,C,G,rs1280163869,64490094.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.00020784421384418072,0.0001910070069031332,0.00024708309145168866,0.0001871839702051512,0.0002012461109311603,0.0002127008897297703,10.0,Severe,11
rs2539534664,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Deletion,frameshift variant,12,64495596 - 64495599,D546fs,Pathogenic,N,-,rs2539534664,64495596.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0004064336254623776,0.0006297422857940545,0.0003196456434836538,0.0004204289949360565,0.000327661660073782,0.0003346895430243413,10.0,Severe,13
rs2539534855,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,splice acceptor variant,12,64495697,,Likely pathogenic,A,T,rs2539534855,64495697.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0011500108681944295,0.001151301952611726,0.0011658677556777625,0.001206594809102285,0.0007310586162919373,0.0014952312072884358,9.1,Severe,36
12:64495748,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,nonsense,12,64495748,Q565*,Pathogenic,C,T,12:64495748,64495748.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.00011708028231558471,0.00016223877483142343,0.00013342891808681824,9.37800011378303e-05,0.00014019690123362517,5.575681628822644e-05,10.0,Severe,5
rs2136087722,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Deletion,frameshift variant,12,64496385,E580fs,Pathogenic,N,-,rs2136087722,64496385.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0003260320284927004,0.0005045385058204891,0.0003694497620933155,0.0002885406620217673,0.00022449697313807284,0.00024313423938985721,10.0,Severe,7
12:64496407,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,splice donor variant,12,64496407,,Likely pathogenic,G,A,12:64496407,64496407.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0008748354513172846,0.0007976793885779095,0.000944545748306137,0.0004634625350392688,0.001314548970020857,0.0008539406146422511,9.1,Severe,28
12:64496948,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Deletion,,12,64496948,,Pathogenic,N,-,12:64496948,64496948.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0009325738784789431,0.001259214762162024,0.0009680633020903052,0.000601261888775542,0.0005698111317742408,0.0012645183075926036,7.7,Moderate,25
rs2040932099,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Deletion,frameshift variant,12,64496957 - 64496958,Y591fs,Pathogenic,N,-,rs2040932099,64496957.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0003546319550229728,0.00042165332818971474,0.000313900519452857,0.0003335607046740708,0.00041114976305981453,0.00029289545973840717,10.0,Severe,10
12:64497006 - 64497007,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Microsatellite,nonsense,12,64497006 - 64497007,,Pathogenic,-,GCCGGGCGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCGGGTGGATCATGAGGTCAG,12:64497006 - 64497007,64497006.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0004052927140656447,0.0003026734080980297,0.0004828818288697713,0.00042775917460678383,0.0005143762139054451,0.00029877294484819355,10.0,Severe,21
rs2136088227,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Deletion,frameshift variant,12,64497032 - 64497035,S616fs,Pathogenic,N,-,rs2136088227,64497032.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.00022986784581562866,0.0002539819264615532,0.0001435239584903535,0.0001807486505596902,0.00024730478720369866,0.00032377990636284774,10.0,Severe,10
rs2539537276,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,nonsense,12,64497044,W619*,Pathogenic,G,A,rs2539537276,64497044.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.00010691230034997693,0.00012134251589904585,0.00015970309837365408,5.871608514231026e-05,8.100128275445794e-05,0.00011379851958041646,10.0,Severe,6
rs2539537429,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,splice acceptor variant,12,64497162,,Likely pathogenic,G,A,rs2539537429,64497162.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0007602191017521194,0.000750013062240783,0.0009787336679912178,0.0006610064666090528,0.0007220124258578162,0.0006893298860617276,9.1,Severe,29
rs2539537514,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Deletion,frameshift variant,12,64497217,D639fs,Pathogenic,N,-,rs2539537514,64497217.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0006366139227235657,0.0004693149144600148,0.0008736255912867555,0.0007304829343976656,0.00033629438006763985,0.0007733517934057529,10.0,Severe,24
rs2136088420,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,nonsense,12,64497234,S645*,Pathogenic,C,G,rs2136088420,64497234.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0003687228052651083,0.0006683266485002492,0.0002485389301254287,0.00027505440464037096,0.0004267143119314197,0.00022497973112807303,10.0,Severe,13
rs2539537579,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Deletion,frameshift variant,12,64497256,N652fs,Pathogenic,N,-,rs2539537579,64497256.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.00030071558129855043,0.0003888263714161898,0.00027049553699099875,0.00017700942346256718,0.0003840980777080494,0.00028314849691494685,10.0,Severe,7
rs1565824978,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,splice acceptor variant,12,64497646,,Likely pathogenic,A,T,rs1565824978,64497646.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0005175513765597952,0.0007024754697234951,0.0003832343649440021,0.0005733053250348005,0.0005777377276280193,0.00035100399546865907,9.1,Severe,16
rs2136088934,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),Microsatellite,frameshift variant,12,64497658 - 64497659,L658fs,Pathogenic,N,-,rs2136088934,64497658.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.0005553418566247241,0.0006855607352432208,0.0007677533997512125,0.0005644765223959171,0.00044501811692622265,0.00031390050880704645,10.0,Severe,15
rs2136088954,TBK1,Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD4),single nucleotide variant,nonsense,12,64497666,Q660*,Likely pathogenic,C,T,rs2136088954,64497666.0,TBK1,12,ALS_FTD,Adult,50-70 years,Variable,0.78,Often late onset; cognitive involvement common,7.0,0.00041746513558828144,0.0005767224822497295,0.0005389164334610923,0.0001966097055793717,0.0004712847180781481,0.00030379233857306547,9.8,Severe,7
rs121909542,ANG|EGILA|RNASE4,Amyotrophic lateral sclerosis type 9 (ALS9),single nucleotide variant,non-coding transcript variant|missense variant|intron variant,14,20693719,S52N,Likely pathogenic,G,A,rs121909542,20693719.0,ANG,14,ALS9_Classical,Adult,50-70 years,Variable,0.68,Rare; angiogenin pathway,6.0,0.002588762789173821,0.004185107418594037,0.0033043046476724965,0.002341305768767516,0.00117752567522292,0.0019355704356121375,6.0,Moderate,77
15:44563294,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,single nucleotide variant,nonsense,15,44563294,"Q2274*, Q2387*, Q2339*",Likely pathogenic,C,T,15:44563294,44563294.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0006934288088783406,0.0010522191516363355,0.0007913768849446423,0.0004184691930323695,0.00034321121785073306,0.0008618675969276226,7.0,Moderate,18
15:44564602,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,single nucleotide variant,nonsense,15,44564602,"E2366*, E2253*, E2318*",Likely pathogenic,G,T,15:44564602,44564602.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0003630312384318586,0.0004884096734878646,0.0004345524172913026,0.00026296039999299686,0.0002182844113737644,0.0004109492900133645,7.0,Moderate,5
15:44565994,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,single nucleotide variant,nonsense,15,44565994,"Q2287*, Q2174*, Q2239*",Pathogenic,C,T,15:44565994,44565994.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0005097272068058025,0.0005010633047292383,0.0005776310003112624,0.0005773518121515661,0.00041908664125002654,0.0004735032755869194,7.7,Moderate,12
15:44566277 - 44566287,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Deletion,frameshift variant,15,44566277 - 44566287,"G2145fs, G2210fs, G2258fs",Likely pathogenic,N,-,15:44566277 - 44566287,44566277.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.00027490702095644867,0.00019471320780139277,0.00029514396831217793,0.00025801496460914764,0.0002995195832776004,0.0003271433807819245,7.0,Moderate,7
15:44567583,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Deletion,nonsense,15,44567583,,Likely pathogenic,N,-,15:44567583,44567583.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.00011685908397814096,0.00016352720983565507,8.513584987422752e-05,9.41319912051545e-05,0.00011128969517119395,0.00013021067380447374,7.0,Moderate,1
15:44570524,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,single nucleotide variant,splice donor variant,15,44570524,,Likely pathogenic,G,C,15:44570524,44570524.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0007498582090579369,0.00081804212717029,0.0009285229795653117,0.0005476098241919581,0.0010303304183926264,0.0004247856959694992,6.5,Moderate,15
15:44572681,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,single nucleotide variant,splice donor variant,15,44572681,,Likely pathogenic,T,C,15:44572681,44572681.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.00017311131104910362,0.0002528159359188413,0.00016407659590847388,0.0001088817151333944,0.0001459373460570769,0.00019384496222773148,6.5,Moderate,4
15:44572773,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,single nucleotide variant,nonsense,15,44572773,"Q2037*, Q1972*, Q2085*",Likely pathogenic,C,T,15:44572773,44572773.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0005778640034897753,0.0007588569138017573,0.0004551207305607383,0.000364521606661714,0.0004665025104950881,0.0008443182559295788,7.0,Moderate,16
15:44572822,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,single nucleotide variant,splice acceptor variant,15,44572822,,Likely pathogenic,A,G,15:44572822,44572822.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.000978564347094684,0.001551543559051694,0.0008230006024078426,0.0005494738074438314,0.0009568210960501329,0.001011982670519919,6.5,Moderate,43
15:44573558,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,single nucleotide variant,nonsense|intron variant,15,44573558,"S2065*, S2017*",Likely pathogenic,C,A,15:44573558,44573558.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0003084336213127198,0.00022750873160128684,0.00036293063976026573,0.00027187060610536486,0.0004221558413075102,0.0002577022877891713,7.0,Moderate,7
15:44574897 - 44574901,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Deletion,splice donor variant|intron variant,15,44574897 - 44574901,,Likely pathogenic,N,-,15:44574897 - 44574901,44574897.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.00034974663497338286,0.00036586795174570007,0.0002607281142292019,0.00016682086268016985,0.0005834564009479399,0.0003718598452639025,6.5,Moderate,8
15:44583974 - 44583983,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Deletion,frameshift variant,15,44583974 - 44583983,"Y1852fs, Y1900fs",Likely pathogenic,N,-,15:44583974 - 44583983,44583974.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.00035195565587503423,0.0006708784223440606,0.000306634593403915,0.00019431424696813524,0.0002732799282121265,0.0003146710884469336,7.0,Moderate,10
15:44584003,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,single nucleotide variant,nonsense,15,44584003,"E1845*, E1893*",Likely pathogenic,G,T,15:44584003,44584003.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0006457787300713452,0.0008189075564512321,0.0006004637115291499,0.0009600160100621616,0.000373934170407188,0.00047557220190699455,7.0,Moderate,20
15:44584081,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Deletion,frameshift variant,15,44584081,"E1867fs, E1819fs",Likely pathogenic,N,-,15:44584081,44584081.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0006266619832259566,0.0005896515259419566,0.0010210752897233887,0.0005443290793834661,0.0005752099178974981,0.00040304410318347346,7.0,Moderate,16
15:44589289 - 44589290,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Duplication,frameshift variant,15,44589289 - 44589290,L1623fs,Likely pathogenic,N,NN,15:44589289 - 44589290,44589289.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0010361580936465282,0.0012224062667547252,0.0012869474473190183,0.0007512384237647977,0.0011448152733230458,0.0007753830570710534,7.0,Moderate,29
15:44589290,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Deletion,frameshift variant,15,44589290,L1623fs,Pathogenic,N,-,15:44589290,44589290.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0002941719454737213,0.00035010291607220114,0.00037899613366191535,0.0002527946742251443,0.0002202224520104648,0.00026874355139888103,7.7,Moderate,12
15:44589327,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,single nucleotide variant,nonsense,15,44589327,Q1611*,Likely pathogenic,C,T,15:44589327,44589327.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0010609023991591411,0.0015849968231579678,0.0011059310774300312,0.0004243663715075131,0.0014461477742162344,0.0007430699494839596,7.0,Moderate,34
15:44595314,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Deletion,frameshift variant,15,44595314,L1527fs,Likely pathogenic,N,-,15:44595314,44595314.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0006239256331381631,0.0005797565251618342,0.0006658676287936681,0.0006164872550140172,0.0005157591171598864,0.0007417576395614101,7.0,Moderate,22
rs2140971559,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,single nucleotide variant,nonsense,15,44596085,Q1478*,Pathogenic,C,T,rs2140971559,44596085.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0006719917647826446,0.0008771035222950651,0.0006317156659509177,0.0006379358885261294,0.000497341423796751,0.0007158623233443595,7.7,Moderate,14
15:44596110 - 44596113,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Deletion,frameshift variant,15,44596110 - 44596113,I1469fs,Likely pathogenic,N,-,15:44596110 - 44596113,44596110.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0004902402458488666,0.00044657187683727037,0.0005198388424399966,0.0004524153934119217,0.0005562394760648678,0.000476135640490277,7.0,Moderate,18
15:44596240 - 44596241,LOC130056973|SPG11,"Amyotrophic lateral sclerosis, unspecified type",Deletion,frameshift variant,15,44596240 - 44596241,K1426fs,Likely pathogenic,N,-,15:44596240 - 44596241,44596240.0,LOC130056973,15,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.0005061386560829868,0.0006098490364153132,0.0004932995783043105,0.0006076656155853552,0.0003011800449339305,0.0005186990051760246,8.4,Severe,10
15:44596945,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,single nucleotide variant,splice acceptor variant,15,44596945,,Likely pathogenic,A,C,15:44596945,44596945.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.00024656101411755366,0.0002098247998249759,0.00023365154279638944,0.0002887532918000371,0.0003398770521194408,0.000160698384046925,6.5,Moderate,5
15:44598265 - 44598266,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Microsatellite,frameshift variant,15,44598265 - 44598266,R1334fs,Likely pathogenic,N,-,15:44598265 - 44598266,44598265.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0007671480817711639,0.0008259544693794375,0.0005543272580522522,0.0006584548250017172,0.0008699958477505496,0.0009270080086718634,7.0,Moderate,23
15:44598363 - 44598364,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Duplication,frameshift variant,15,44598363 - 44598364,S1302fs,Likely pathogenic,N,NN,15:44598363 - 44598364,44598363.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0008983477910416423,0.001550186269597703,0.0008363264176251391,0.0004401737160504182,0.0010614667724263777,0.0006035857795085742,7.0,Moderate,20
15:44598740,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Deletion,frameshift variant,15,44598740,G1262fs,Likely pathogenic,N,-,15:44598740,44598740.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0004620361153169357,0.0007051947713627893,0.0006441006977355311,0.00022219833529287973,0.0002872359723215874,0.00045145079987189116,7.0,Moderate,13
15:44598779 - 44598780,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Insertion,frameshift variant,15,44598779 - 44598780,S1249fs,Likely pathogenic,-,CTACC,15:44598779 - 44598780,44598779.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0008489694370017176,0.0006515768681980588,0.0008775661925509756,0.0008858805979654512,0.0008500213327112857,0.0009798021935828163,7.0,Moderate,32
15:44608525,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Deletion,frameshift variant,15,44608525,K1125fs,Likely pathogenic,N,-,15:44608525,44608525.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0006847972797324688,0.0008626838000758135,0.0006846835379142536,0.00038788732858626704,0.0007335885704119748,0.0007551431616740347,7.0,Moderate,27
15:44610986,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,single nucleotide variant,splice acceptor variant,15,44610986,,Likely pathogenic,G,C,15:44610986,44610986.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0008645712547380651,0.0006582807483708176,0.0006434476277428265,0.0008309630501338511,0.0010450968059248183,0.001145068041518012,6.5,Moderate,27
15:44613537,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,single nucleotide variant,splice acceptor variant,15,44613537,,Likely pathogenic,G,A,15:44613537,44613537.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,5.744643728143792e-05,8.08845160282049e-05,4.8470818079738746e-05,3.063034878529292e-05,6.611766963917864e-05,6.112883387477441e-05,6.5,Moderate,1
15:44615384 - 44615385,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Duplication,frameshift variant,15,44615384 - 44615385,Y1006fs,Likely pathogenic,N,NN,15:44615384 - 44615385,44615384.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0003424344880786421,0.0004070624772291153,0.0004255929507407094,0.00015059968238358587,0.0004001438074193564,0.0003287735226204435,7.0,Moderate,8
15:44615416 - 44615417,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Deletion,frameshift variant,15,44615416 - 44615417,Y995fs,Likely pathogenic,N,-,15:44615416 - 44615417,44615416.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.00048560795150931756,0.0004849514243351588,0.0005128521145997843,0.00042155137745328574,0.0003625218533778228,0.0006461629877805362,7.0,Moderate,21
15:44615538,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,single nucleotide variant,nonsense,15,44615538,E955*,Likely pathogenic,G,T,15:44615538,44615538.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.00031150706711920314,0.00048603626893111833,0.00021870514110766402,0.00025440047362372965,0.00019219781403669045,0.00040619563789681315,7.0,Moderate,6
rs750101275,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Duplication,frameshift variant,15,44621766 - 44621767,S871fs,Pathogenic,N,NN,rs750101275,44621766.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0006546757362978004,0.0005980087629132496,0.0007339205270747627,0.0002770305152483912,0.0008218368715647663,0.0008425820046878321,7.7,Moderate,25
rs2083790483,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Deletion,frameshift variant,15,44622794,F750fs,Pathogenic,N,-,rs2083790483,44622794.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.00027345930244551073,0.00036951342591883354,0.00022261192725382933,0.0003395884590994856,0.00016406351935291006,0.00027151918060249505,7.7,Moderate,6
15:44628748 - 44628749,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Deletion,frameshift variant,15,44628748 - 44628749,D663fs,Likely pathogenic,N,-,15:44628748 - 44628749,44628748.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.000689453861040045,0.0008201189205684126,0.0007705495501572682,0.0006307191785918609,0.0005309845078602218,0.0006948971480224614,7.0,Moderate,27
15:44629276 - 44629279,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Deletion,frameshift variant,15,44629276 - 44629279,F617fs,Pathogenic,N,-,15:44629276 - 44629279,44629276.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0004098903840341965,0.0005530024018905781,0.0005682721874571289,0.0002235229668506031,0.00019691993657364225,0.00050773442739903,7.7,Moderate,13
15:44629304,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,single nucleotide variant,nonsense,15,44629304,S607*,Likely pathogenic,C,G,15:44629304,44629304.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.00014207312986564723,0.00012584248438382784,0.00015997728984441667,0.00017902748975854763,0.00014928862114679873,9.622976419464522e-05,7.0,Moderate,3
rs1226110412,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,single nucleotide variant,nonsense,15,44651515,Q478*,Pathogenic,C,T,rs1226110412,44651515.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0001536798411569833,0.00019952669931991204,0.00019645667228626696,0.00016798422887399103,0.00013510116936101945,6.933043594372716e-05,7.7,Moderate,9
15:44651672,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Deletion,frameshift variant,15,44651672,I425fs,Likely pathogenic,N,-,15:44651672,44651672.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.00018849885810628454,0.00026860599181630047,0.00015115001041993012,0.00016286080949336995,0.0001787887692507706,0.00018108870955105153,7.0,Moderate,6
15:44657171,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,Deletion,frameshift variant,15,44657171,S265fs,Likely pathogenic,N,-,15:44657171,44657171.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0008229378135061457,0.0008376259792111118,0.0008354972985425426,0.0005741085974511089,0.0011045673951214467,0.0007628897972045183,7.0,Moderate,28
15:44657213,SPG11,Amyotrophic lateral sclerosis type 5 (ALS5) - Juvenile,single nucleotide variant,nonsense,15,44657213,Q251*,Likely pathogenic,C,T,15:44657213,44657213.0,SPG11,15,ALS5_Juvenile,Juvenile,7-23 years,Slow,0.55,May have thin corpus callosum; cognitive involvement possible,5.0,0.0007065391769890879,0.000655554757691991,0.0006995245392148406,0.0008861797196063792,0.0006302943088662981,0.0006611425595659311,7.0,Moderate,22
rs2053207945,CHRNA3,"Amyotrophic lateral sclerosis, unspecified type",Deletion,frameshift variant|non-coding transcript variant,15,78601917,L242fs,Likely pathogenic,N,-,rs2053207945,78601917.0,CHRNA3,15,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.0001827330082453433,0.00024139839252436694,0.00019763754989160699,0.0001141084009004404,0.00018754400987620081,0.00017297668803410138,8.4,Severe,10
rs2053208751,CHRNA3,"Amyotrophic lateral sclerosis, unspecified type",Insertion,frameshift variant|non-coding transcript variant,15,78601933 - 78601934,I237fs,Likely pathogenic,-,G,rs2053208751,78601933.0,CHRNA3,15,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.00014390235232569364,0.0001518218974964705,0.0001722650028060526,5.1325696426291406e-05,0.00017960938906965354,0.0001644897758300003,8.4,Severe,6
rs2053501632,CHRNA3,"Amyotrophic lateral sclerosis, unspecified type",Insertion,frameshift variant|non-coding transcript variant,15,78618636 - 78618637,T83fs,Likely pathogenic,-,G,rs2053501632,78618636.0,CHRNA3,15,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.0008726620038131282,0.0010761882554431506,0.0009549167267842514,0.0009173715582387254,0.0008223606630236442,0.0005924728155758695,8.4,Severe,32
rs2053539304,CHRNA3,"Amyotrophic lateral sclerosis, unspecified type",single nucleotide variant,missense variant|initiator_codon_variant|non-coding transcript variant,15,78620794,M1V,Likely pathogenic,A,G,rs2053539304,78620794.0,CHRNA3,15,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.0007329791008464006,0.0008514941698824841,0.000972638495800286,0.000633614024655159,0.0006379635941660873,0.0005691852197279863,6.0,Moderate,17
rs2544251972,FUS,Amyotrophic lateral sclerosis type 6 (ALS6),single nucleotide variant,nonsense|non-coding transcript variant,16,31183920,"Q84*, Q85*",Pathogenic,C,T,rs2544251972,31183920.0,FUS,16,ALS6_Aggressive,Variable,20-50 years,Rapid,0.9,Often aggressive course; juvenile forms very severe,9.0,0.000183082390322203,0.0001829758169451291,0.0001611535194777687,0.00025165762755878285,0.00012123073595180203,0.00019839425167753234,10.0,Severe,7
rs2144138894,FUS,Amyotrophic lateral sclerosis type 6 (ALS6),Duplication,frameshift variant|non-coding transcript variant,16,31190839 - 31190840,"G464fs, G461fs, G465fs",Pathogenic,N,NN,rs2144138894,31190839.0,FUS,16,ALS6_Aggressive,Variable,20-50 years,Rapid,0.9,Often aggressive course; juvenile forms very severe,9.0,0.00020962218382105158,0.00017239067716918598,0.0001833765108697372,0.00016018264967125013,0.0003108434621297919,0.00022131761926529284,10.0,Severe,7
rs2079347087,FUS,Amyotrophic lateral sclerosis type 6 (ALS6),single nucleotide variant,splice acceptor variant,16,31190962,,Pathogenic,G,T,rs2079347087,31190962.0,FUS,16,ALS6_Aggressive,Variable,20-50 years,Rapid,0.9,Often aggressive course; juvenile forms very severe,9.0,0.0006073218690730916,0.0007643674239527293,0.000770241300372551,0.0004713354734807394,0.0003389394296232977,0.0006917257179361404,10.0,Severe,24
rs2544279075,FUS,Amyotrophic lateral sclerosis type 6 (ALS6),Deletion,frameshift variant|non-coding transcript variant,16,31191016 - 31191055,"Y480fs, Y483fs, Y484fs",Pathogenic,N,-,rs2544279075,31191016.0,FUS,16,ALS6_Aggressive,Variable,20-50 years,Rapid,0.9,Often aggressive course; juvenile forms very severe,9.0,0.00024634767347589257,0.0003025007970254113,0.00018363393945197926,0.0001927926007787457,0.00035944029864732447,0.0001933707314760021,10.0,Severe,6
16:31191061 - 31191062,FUS,Amyotrophic lateral sclerosis type 6 (ALS6),Duplication,frameshift variant|non-coding transcript variant,16,31191061 - 31191062,"G496fs, G500fs, G499fs",Likely pathogenic,N,NN,16:31191061 - 31191062,31191061.0,FUS,16,ALS6_Aggressive,Variable,20-50 years,Rapid,0.9,Often aggressive course; juvenile forms very severe,9.0,0.0005690274418240365,0.0005355361706015205,0.0004497045952431976,0.0006605655907777552,0.0004030303003705302,0.0007963005521271788,10.0,Severe,9
16:31191062,FUS,Amyotrophic lateral sclerosis type 6 (ALS6),Deletion,frameshift variant|non-coding transcript variant,16,31191062,"G495fs, G498fs, G499fs",Pathogenic,N,-,16:31191062,31191062.0,FUS,16,ALS6_Aggressive,Variable,20-50 years,Rapid,0.9,Often aggressive course; juvenile forms very severe,9.0,2.3988679627360304e-05,3.022270257302512e-05,2.837029019911027e-05,1.9813394469559195e-05,2.6580739363891468e-05,1.4956271531215466e-05,10.0,Severe,3
rs2144140268,FUS,Amyotrophic lateral sclerosis type 6 (ALS6),Duplication,frameshift variant|non-coding transcript variant,16,31191068 - 31191069,"G500fs, G501fs, G497fs",Pathogenic,N,NN,rs2144140268,31191068.0,FUS,16,ALS6_Aggressive,Variable,20-50 years,Rapid,0.9,Often aggressive course; juvenile forms very severe,9.0,0.0002146443503137089,0.0002665663220222406,0.00029381263731682574,0.00014509145525646864,0.0001467375982809606,0.00022101373869204887,10.0,Severe,5
rs1596912983,FUS,Amyotrophic lateral sclerosis type 6 (ALS6),Microsatellite,frameshift variant|non-coding transcript variant,16,31191075 - 31191076,"G500fs, G503fs, G504fs",Pathogenic,N,NN,rs1596912983,31191075.0,FUS,16,ALS6_Aggressive,Variable,20-50 years,Rapid,0.9,Often aggressive course; juvenile forms very severe,9.0,5.101775904974866e-05,8.340258154715654e-05,4.2882855260704746e-05,4.1378565875703855e-05,5.2534655363253455e-05,3.4890137201924714e-05,10.0,Severe,2
rs2079350332,FUS,Amyotrophic lateral sclerosis type 6 (ALS6),Duplication,frameshift variant|non-coding transcript variant,16,31191077 - 31191078,"G503fs, G504fs, G500fs",Pathogenic,N,NN,rs2079350332,31191077.0,FUS,16,ALS6_Aggressive,Variable,20-50 years,Rapid,0.9,Often aggressive course; juvenile forms very severe,9.0,0.0004309785838632665,0.0003656319411739958,0.0006113720546233318,0.0003744919153587209,0.00020014179545813885,0.000603255212702145,10.0,Severe,16
rs2544279594,FUS,Amyotrophic lateral sclerosis type 6 (ALS6),Duplication,frameshift variant|non-coding transcript variant,16,31191099 - 31191100,"M507fs, M510fs, M511fs",Pathogenic,N,NN,rs2544279594,31191099.0,FUS,16,ALS6_Aggressive,Variable,20-50 years,Rapid,0.9,Often aggressive course; juvenile forms very severe,9.0,0.00011684907885448339,0.00013540888304719757,0.00011905381197472755,8.303964558925679e-05,0.0001403460690730045,0.00010639698458823056,10.0,Severe,4
rs1555509609,FUS,Amyotrophic lateral sclerosis type 6 (ALS6),single nucleotide variant,missense variant|non-coding transcript variant,16,31191109,"R514W, R510W, R513W",Likely pathogenic,A,T,rs1555509609,31191109.0,FUS,16,ALS6_Aggressive,Variable,20-50 years,Rapid,0.9,Often aggressive course; juvenile forms very severe,9.0,0.0014954025560721148,0.0019205122555322903,0.0017351160408183093,0.0008123330737785414,0.0010844387352120937,0.0019246126750193404,9.0,Severe,42
rs2079351113,FUS,Amyotrophic lateral sclerosis type 6 (ALS6),single nucleotide variant,splice donor variant,16,31191111,,Pathogenic,G,A,rs2079351113,31191111.0,FUS,16,ALS6_Aggressive,Variable,20-50 years,Rapid,0.9,Often aggressive course; juvenile forms very severe,9.0,0.0003032662293514394,0.00035790911982040057,0.00038689842286655253,0.0003878676422848331,0.00019806868931980772,0.00018558727246560295,10.0,Severe,10
rs1596914113,FUS,Amyotrophic lateral sclerosis type 6 (ALS6),single nucleotide variant,splice acceptor variant,16,31191398,,Likely pathogenic,G,C,rs1596914113,31191398.0,FUS,16,ALS6_Aggressive,Variable,20-50 years,Rapid,0.9,Often aggressive course; juvenile forms very severe,9.0,0.00022324654928196846,0.00023072592763315577,0.00022295713985700044,0.0002007567309831485,0.00027546302051409844,0.00018632992742243905,10.0,Severe,6
16:31191399,FUS,Amyotrophic lateral sclerosis type 6 (ALS6),single nucleotide variant,missense variant|non-coding transcript variant,16,31191399,"R510S, R513S, R514S",Pathogenic,G,T,16:31191399,31191399.0,FUS,16,ALS6_Aggressive,Variable,20-50 years,Rapid,0.9,Often aggressive course; juvenile forms very severe,9.0,0.00018292022612394475,0.0002778612024191565,0.00017928551657256798,0.00012148344392058573,0.00020046899671174735,0.00013550197099566612,9.9,Severe,3
rs121909669,FUS,Amyotrophic lateral sclerosis type 6 (ALS6),single nucleotide variant,missense variant|non-coding transcript variant,16,31191410,"R518K, R514K, R517K",Pathogenic,G,A,rs121909669,31191410.0,FUS,16,ALS6_Aggressive,Variable,20-50 years,Rapid,0.9,Often aggressive course; juvenile forms very severe,9.0,0.00011721341785462342,0.0001913157796092976,8.705430337164295e-05,6.0123130209507835e-05,0.00011779953470867235,0.0001297743413739964,9.9,Severe,8
rs1567479067,FUS,Amyotrophic lateral sclerosis type 6 (ALS6),single nucleotide variant,nonsense|non-coding transcript variant,16,31191412,"Q515*, Q518*, Q519*",Pathogenic,C,T,rs1567479067,31191412.0,FUS,16,ALS6_Aggressive,Variable,20-50 years,Rapid,0.9,Often aggressive course; juvenile forms very severe,9.0,0.0001937004070269687,0.00019179030397523653,0.00013670596362171824,0.0001994055029679018,0.00026141069896879805,0.00017918956560118886,10.0,Severe,4
rs544088874,FUS,Amyotrophic lateral sclerosis type 6 (ALS6),single nucleotide variant,missense variant|non-coding transcript variant,16,31191428,"R523M, R520M, R524M",Likely pathogenic,G,T,rs544088874,31191428.0,FUS,16,ALS6_Aggressive,Variable,20-50 years,Rapid,0.9,Often aggressive course; juvenile forms very severe,9.0,0.0017854463791428716,0.0016503150019738552,0.0015306558865044067,0.0008270458315108349,0.002659687009977563,0.002259528165747698,9.0,Severe,59
rs1555509699,FUS,Amyotrophic lateral sclerosis type 6 (ALS6),single nucleotide variant,missense variant|non-coding transcript variant,16,31191430,"P521S, P524S, P525S",Likely pathogenic,C,T,rs1555509699,31191430.0,FUS,16,ALS6_Aggressive,Variable,20-50 years,Rapid,0.9,Often aggressive course; juvenile forms very severe,9.0,0.001776127737928574,0.0016734727862455585,0.001889986100448898,0.002085775553438194,0.0020285760365405625,0.0012028282129696566,9.0,Severe,50
rs1555509699,FUS,Amyotrophic lateral sclerosis type 6 (ALS6),single nucleotide variant,missense variant|non-coding transcript variant,16,31191430,"P521T, P525T, P524T",Pathogenic,C,A,rs1555509699,31191430.0,FUS,16,ALS6_Aggressive,Variable,20-50 years,Rapid,0.9,Often aggressive course; juvenile forms very severe,9.0,0.0016102810282914285,0.0014735966330869574,0.001931461103473152,0.0020226399367827197,0.0008232945091503804,0.0018004129589639327,9.9,Severe,60
rs1228194239,FUS,Amyotrophic lateral sclerosis type 6 (ALS6),single nucleotide variant,missense variant|non-coding transcript variant,16,31191434,"Y525C, Y522C, Y526C",Pathogenic,A,G,rs1228194239,31191434.0,FUS,16,ALS6_Aggressive,Variable,20-50 years,Rapid,0.9,Often aggressive course; juvenile forms very severe,9.0,0.0002126121703930316,0.0001751825383843719,0.00016836570465134212,0.00018298740433026593,0.00028166012847070964,0.00025486507612846834,9.9,Severe,10
rs2513075471,UNC13A,"Amyotrophic lateral sclerosis, unspecified type",single nucleotide variant,missense variant,19,17648579,"F554L, F556L",Likely pathogenic,C,A,rs2513075471,17648579.0,UNC13A,19,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.001072451461332088,0.0014670074215429076,0.0012639275473110558,0.001089016334194874,0.0009441806233092222,0.0005981253803023813,6.0,Moderate,27
20:761006 - 765794,SLC52A3,Brown-Vialetto-Van Laere syndrome 1 (BVVLS1),Deletion,,20,761006 - 765794,,Pathogenic,N,-,20:761006 - 765794,761006.0,SLC52A3,20,BVVL_Juvenile,Juvenile,1-20 years,Variable,0.65,Bulbar palsy with hearing loss; TREATABLE with high-dose riboflavin,6.0,0.0011303918549496145,0.0008791329347456354,0.0008439504579539291,0.0008918084528120808,0.0012809911932801185,0.0017560762359563086,6.6,Moderate,25
rs1555783467,SLC52A3,Brown-Vialetto-Van Laere syndrome 1 (BVVLS1),single nucleotide variant,missense variant,20,761120,G439D,Likely pathogenic,G,A,rs1555783467,761120.0,SLC52A3,20,BVVL_Juvenile,Juvenile,1-20 years,Variable,0.65,Bulbar palsy with hearing loss; TREATABLE with high-dose riboflavin,6.0,0.0014326762389845747,0.0020315941416451083,0.0015979238288446136,0.001291260321854847,0.0013209555917325173,0.0009216473108457867,6.0,Moderate,38
rs767916187,SLC52A3,Brown-Vialetto-Van Laere syndrome 1 (BVVLS1),single nucleotide variant,nonsense,20,763718,Q285*,Pathogenic,C,T,rs767916187,763718.0,SLC52A3,20,BVVL_Juvenile,Juvenile,1-20 years,Variable,0.65,Bulbar palsy with hearing loss; TREATABLE with high-dose riboflavin,6.0,0.0006215237239304511,0.0009895723561402334,0.0006112204644989612,0.0006416762471521759,0.00028708025125742095,0.0005780693006034635,9.2,Severe,18
rs2514848897,SLC52A3,Brown-Vialetto-Van Laere syndrome 1 (BVVLS1),Deletion,frameshift variant,20,763780 - 763781,S264fs,Pathogenic,N,-,rs2514848897,763780.0,SLC52A3,20,BVVL_Juvenile,Juvenile,1-20 years,Variable,0.65,Bulbar palsy with hearing loss; TREATABLE with high-dose riboflavin,6.0,0.0007273207448784439,0.0010070491026013023,0.0007087548627268878,0.00031786036312852155,0.0008523334950167725,0.0007506059009187353,9.2,Severe,28
rs2514849071,SLC52A3,Brown-Vialetto-Van Laere syndrome 1 (BVVLS1),Deletion,frameshift variant,20,763829,W248fs,Likely pathogenic,N,-,rs2514849071,763829.0,SLC52A3,20,BVVL_Juvenile,Juvenile,1-20 years,Variable,0.65,Bulbar palsy with hearing loss; TREATABLE with high-dose riboflavin,6.0,0.0005647521382317968,0.0005275386434803083,0.000683220127906151,0.00040256149239645196,0.0006185536476914716,0.000591886779684602,8.4,Severe,17
20:763909,SLC52A3,Brown-Vialetto-Van Laere syndrome 1 (BVVLS1),Deletion,frameshift variant,20,763909,L221fs,Likely pathogenic,N,-,20:763909,763909.0,SLC52A3,20,BVVL_Juvenile,Juvenile,1-20 years,Variable,0.65,Bulbar palsy with hearing loss; TREATABLE with high-dose riboflavin,6.0,0.0007271352921341446,0.0008556030540672369,0.0007685481320209835,0.0007347500817944505,0.0006336543471415273,0.0006431208456465244,8.4,Severe,19
rs1383679424,SLC52A3,Brown-Vialetto-Van Laere syndrome 1 (BVVLS1),Duplication,frameshift variant,20,765290 - 765291,G162fs,Pathogenic,N,NN,rs1383679424,765290.0,SLC52A3,20,BVVL_Juvenile,Juvenile,1-20 years,Variable,0.65,Bulbar palsy with hearing loss; TREATABLE with high-dose riboflavin,6.0,0.0005376426776910695,0.0003824910182371091,0.0006873881971245707,0.0006703431944158542,0.00063677387353203,0.00031121710514578365,9.2,Severe,21
rs769740240,SLC52A3,Brown-Vialetto-Van Laere syndrome 1 (BVVLS1),single nucleotide variant,nonsense,20,765367,Y136*,Pathogenic,C,G,rs769740240,765367.0,SLC52A3,20,BVVL_Juvenile,Juvenile,1-20 years,Variable,0.65,Bulbar palsy with hearing loss; TREATABLE with high-dose riboflavin,6.0,8.233238099978445e-05,0.00013207651089743323,8.100953175711365e-05,4.671168957735965e-05,0.0001005268564140421,5.133731635297364e-05,9.2,Severe,2
rs767263985,SLC52A3,Brown-Vialetto-Van Laere syndrome 1 (BVVLS1),single nucleotide variant,missense variant,20,765401,T125I,Likely pathogenic,C,T,rs767263985,765401.0,SLC52A3,20,BVVL_Juvenile,Juvenile,1-20 years,Variable,0.65,Bulbar palsy with hearing loss; TREATABLE with high-dose riboflavin,6.0,0.00015434676148822916,0.0001982759894787775,0.0001559738809149982,8.794665484917928e-05,0.00015330283856395533,0.00017623444363423551,6.0,Moderate,4
rs1486271481,SLC52A3,Brown-Vialetto-Van Laere syndrome 1 (BVVLS1),single nucleotide variant,nonsense,20,765482,W98*,Pathogenic,G,A,rs1486271481,765482.0,SLC52A3,20,BVVL_Juvenile,Juvenile,1-20 years,Variable,0.65,Bulbar palsy with hearing loss; TREATABLE with high-dose riboflavin,6.0,0.0002500457245858924,0.00026996451549551897,0.00035700657527834795,0.0002386141200183539,0.00021802172374658297,0.00016662168839065794,9.2,Severe,5
rs1986662202,SLC52A3,Brown-Vialetto-Van Laere syndrome 1 (BVVLS1),Deletion,frameshift variant,20,765690,L29fs,Pathogenic,N,-,rs1986662202,765690.0,SLC52A3,20,BVVL_Juvenile,Juvenile,1-20 years,Variable,0.65,Bulbar palsy with hearing loss; TREATABLE with high-dose riboflavin,6.0,0.0002690176063408625,0.00025746811430846385,0.00027600986997637736,0.0002856348645010935,0.0003310894120889534,0.00019488577082942435,9.2,Severe,8
rs2514853352,SLC52A3,Brown-Vialetto-Van Laere syndrome 1 (BVVLS1),single nucleotide variant,nonsense,20,765724,W17*,Pathogenic,G,A,rs2514853352,765724.0,SLC52A3,20,BVVL_Juvenile,Juvenile,1-20 years,Variable,0.65,Bulbar palsy with hearing loss; TREATABLE with high-dose riboflavin,6.0,0.00011850836170304742,0.00018016783677662408,0.00010623751173618513,9.86629790177416e-05,0.00014340183964336547,6.407164134132083e-05,9.2,Severe,3
rs1568807314,SOD1|SOD1-DT,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31659785,V6M,Likely pathogenic,G,A,rs1568807314,31659785.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0008437220069126919,0.0014774914378092535,0.000806970452432664,0.0005971469154543059,0.0007314672427576258,0.0006055339861096103,7.0,Moderate,33
rs1312702973,SOD1|SOD1-DT,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31659788,C7G,Likely pathogenic,T,G,rs1312702973,31659788.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0012820375988143319,0.001644305754617284,0.0014349298379055316,0.0011157517680639197,0.0012144356405206723,0.0010007649929642524,7.0,Moderate,28
rs1312702973,SOD1|SOD1-DT,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31659788,C7S,Pathogenic,T,A,rs1312702973,31659788.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0011471143364885296,0.0010342051324416783,0.0016936057313095513,0.0007435739012780336,0.001254452249166184,0.0010097346682472008,7.7,Moderate,29
rs762628133,SOD1|SOD1-DT,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,non-coding transcript variant|missense variant,21,31659803,D12Y,Likely pathogenic,G,T,rs762628133,31659803.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.001666021263766785,0.0015915684770676963,0.0018960966846582523,0.0016952779055020477,0.0011258305583358437,0.002021332693270085,7.0,Moderate,45
rs1202989817,SOD1-DT|SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31659813,V15G,Likely pathogenic,T,G,rs1202989817,31659813.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.001950914906705402,0.0017590823863983572,0.001922335154813868,0.002464435326441184,0.0023077729411544743,0.0013009487247191255,7.0,Moderate,69
rs121912453,SOD1|SOD1-DT,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31659818,G17C,Likely pathogenic,G,T,rs121912453,31659818.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.00046414860023333466,0.0005787535722631044,0.00045397258684899434,0.0005396154129551693,0.0003550147867472308,0.0003933866423521742,7.0,Moderate,17
rs1555836169,SOD1|SOD1-DT,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31659831,F21C,Pathogenic,T,G,rs1555836169,31659831.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0016213990806952495,0.002026790616143286,0.0013151489958755176,0.000927316367388967,0.0022118203237145063,0.0016259191003539714,7.7,Moderate,60
21:31659837,SOD1|SOD1-DT,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,non-coding transcript variant|missense variant,21,31659837,Q23R,Likely pathogenic,A,G,21:31659837,31659837.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.002446886499621797,0.002078218980701396,0.0026667296023595503,0.001655658631241216,0.0028236167018087905,0.003010208581998034,7.0,Moderate,80
rs1169198442,SOD1|SOD1-DT,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,non-coding transcript variant|missense variant,21,31659837,Q23P,Likely pathogenic,A,C,rs1169198442,31659837.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.001351254820783825,0.0018921191488647465,0.001340872966065837,0.0015106996204424527,0.0013397004224612026,0.0006728819460848866,7.0,Moderate,48
21:31663789,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,splice acceptor variant,21,31663789,,Likely pathogenic,G,A,21:31663789,31663789.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.000915057956386677,0.0011027422251179441,0.0011863135435291842,0.0006142260358190311,0.0008935706315393668,0.0007784373459278586,9.1,Severe,21
rs1555836520,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31663833,L39Q,Likely pathogenic,T,A,rs1555836520,31663833.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.002325769005972608,0.003385235515079082,0.0020264321465922547,0.0019351392991352862,0.0024957223969661246,0.0017863156720902917,7.0,Moderate,67
21:31666473,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31666473,,Likely pathogenic,T,G,21:31666473,31666473.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.00014252568004212893,0.00012674952243649056,9.565903558439655e-05,0.0001990995606649787,9.384786570952474e-05,0.0001972724158152541,7.0,Moderate,4
21:31666479,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31666479,P67R,Likely pathogenic,C,G,21:31666479,31666479.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0008735717957093164,0.0011285735269801062,0.0007881072275075032,0.0005884379517208338,0.0011271269381455448,0.0007356133341925943,7.0,Moderate,36
21:31666482,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31666482,L68P,Likely pathogenic,T,C,21:31666482,31666482.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0014176301769211479,0.0011226441421174852,0.002255219694109072,0.0007108593571632675,0.0010826820982847438,0.00191674559293117,7.0,Moderate,49
rs2049594204,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31666484,S69P,Likely pathogenic,T,C,rs2049594204,31666484.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0006868281698508128,0.0008318248205566109,0.0006367393077259056,0.0007621518162690451,0.00044688107326166864,0.000756543831440834,7.0,Moderate,18
rs2049594311,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31666493,H72Y,Likely pathogenic,C,T,rs2049594311,31666493.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0020718406882487632,0.002108068337058728,0.001185691704024039,0.0015551887737825206,0.0028742653767499645,0.002635989249628564,7.0,Moderate,57
rs2516660280,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31667259,H81Y,Likely pathogenic,C,T,rs2516660280,31667259.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.002243201606099715,0.002277259992227174,0.0028702634018536437,0.00117086834232325,0.0028526155928694217,0.0020450007012250866,7.0,Moderate,74
rs121912458,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31667260,H81R,Pathogenic,A,G,rs121912458,31667260.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.001137456191565192,0.0012121178642792048,0.0009413986354421691,0.0010446798232980608,0.0012358543776516137,0.0012532302571549114,7.7,Moderate,32
rs80265967,SCAF4|SOD1,"Amyotrophic lateral sclerosis, unspecified type",single nucleotide variant,missense variant,21,31667290,D91V,Pathogenic,A,T,rs80265967,31667290.0,SCAF4,21,ALS_Unspecified,Adult,Variable,Variable,0.7,Gene not in curated ALS gene list; assigned default parameters,6.0,0.0002907764530846443,0.00028282124715173055,0.0003082847573684829,0.0003137051564671467,0.0003822343132535338,0.00016683679118232762,6.6,Moderate,10
21:31667296 - 31667297,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),Duplication,,21,31667296 - 31667297,,Likely pathogenic,N,NN,21:31667296 - 31667297,31667296.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0006579932857030266,0.0008799058976040733,0.0007307207339872847,0.00031345608832338874,0.0008215606784838968,0.00054432303011649,7.0,Moderate,23
rs121912437,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31667298,G94S,Pathogenic,G,A,rs121912437,31667298.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0005579320872571571,0.0006452550726834672,0.0007945565171152798,0.00023913604293396878,0.0004417558784754325,0.0006689569250776379,7.7,Moderate,13
rs121912437,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31667298,G94C,Pathogenic,G,T,rs121912437,31667298.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0010235489960341078,0.0014169930849151488,0.0010602608973760328,0.0004358060865389097,0.0009193215811760455,0.0012853633301644026,7.7,Moderate,30
rs121912438,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31667299,G94A,Pathogenic,G,C,rs121912438,31667299.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0015012133128080817,0.001732593573943768,0.0013305752690477702,0.0013849590953206956,0.001453753719114994,0.0016041849066131802,7.7,Moderate,38
rs1555836803,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31667308,D97V,Likely pathogenic,A,T,rs1555836803,31667308.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0010237834366568122,0.0008607284566549943,0.0008071138298548496,0.0013958527694832483,0.0009122527821108595,0.0011429693451801086,7.0,Moderate,36
rs1568810715,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31667322,D102N,Pathogenic,G,A,rs1568810715,31667322.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0014643227038118746,0.0016796785462831092,0.002288205259906779,0.0006876961543512103,0.0014021708397363984,0.0012638627187818753,7.7,Moderate,33
rs1568810715,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31667322,D102H,Pathogenic,G,C,rs1568810715,31667322.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.001284867664297942,0.0018774037786031131,0.0016163415781415705,0.0011391205249031118,0.001045431980939078,0.0007460404589028361,7.7,Moderate,40
rs121912445,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31667331,I105F,Likely pathogenic,A,T,rs121912445,31667331.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0008444778786104417,0.0011562533251247345,0.0011503784701324005,0.0003824660476847564,0.0008310708604821393,0.0007022206896281782,7.0,Moderate,40
rs121912440,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31667337,L107F,Pathogenic,C,T,rs121912440,31667337.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0008674365242503186,0.001269699404229923,0.0008780465705165538,0.0008708601028370056,0.0007028215133284823,0.0006157550303396282,7.7,Moderate,26
rs1601158483,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31667353,C112Y,Pathogenic,G,A,rs1601158483,31667353.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0007137174220585268,0.0009246459932519135,0.0007869574839939821,0.00035422718324104715,0.001144126769582879,0.0003586296802228123,7.7,Moderate,20
rs74315452,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31667356,I113T,Pathogenic,T,C,rs74315452,31667356.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.00021057240260798023,0.0001812671488331658,0.0001536339421310912,0.00012354940643777973,0.0003126053935461622,0.000281806122091702,7.7,Moderate,6
21:31667357,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31667357,I113M,Likely pathogenic,C,G,21:31667357,31667357.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.00151840298828426,0.002386210988016164,0.0014574030894550982,0.0012426691324827967,0.0014361508040222862,0.0010695809274449558,7.0,Moderate,44
rs750335577,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31667360,I114M,Likely pathogenic,T,G,rs750335577,31667360.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0004377705200392523,0.000550361689494309,0.0004521443801688289,0.00020436403494832446,0.00041079021867086507,0.0005711922769139339,7.0,Moderate,8
rs1568810789,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31667362,G115A,Pathogenic,G,C,rs1568810789,31667362.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.001430254540073942,0.0015092151482879344,0.001628578707139032,0.0005915049218016014,0.002019659837976576,0.0014023140851645657,7.7,Moderate,45
21:31667364,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31667364,R116S,Likely pathogenic,C,A,21:31667364,31667364.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0021755256212903805,0.002705228119569845,0.0024173095629464016,0.0008729128074639097,0.0033428746708094098,0.0015393029456623349,7.0,Moderate,75
21:31668471,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31668471,V120F,Likely pathogenic,G,T,21:31668471,31668471.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0018766523902174366,0.0016556616784313928,0.0018408309082245957,0.002337674197563069,0.0019458827389702324,0.0016032124278978935,7.0,Moderate,56
21:31668477,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31668477,E122K,Likely pathogenic,G,A,21:31668477,31668477.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0021401980893036078,0.0025426861308817687,0.0015438787997493967,0.0022100348195794916,0.0022601565399048037,0.0021442341564025785,7.0,Moderate,77
rs1568811372,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31668489,D126N,Likely pathogenic,G,A,rs1568811372,31668489.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0006381331807189752,0.0009056159915549855,0.0007701368106413909,0.0006794064274269014,0.000379293231893457,0.0004562134420781414,7.0,Moderate,23
21:31668490 - 31668491,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),Duplication,frameshift variant,21,31668490 - 31668491,K129fs,Pathogenic,N,NN,21:31668490 - 31668491,31668490.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0005763659339614041,0.000504853541277689,0.000455287718005407,0.0007305738368283751,0.0004964657517199607,0.0006946488219755888,10.0,Severe,28
rs1164911383,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31668490,D126A,Likely pathogenic,A,C,rs1164911383,31668490.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0017005352115863057,0.001213184260138875,0.0020346263123195364,0.001796348622389361,0.00154850336666269,0.0019100134964210667,7.0,Moderate,44
rs121912454,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31668493,L127S,Pathogenic,T,C,rs121912454,31668493.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0016686456381129367,0.002156445495316604,0.0013447306786875998,0.0012874098541162718,0.0019200383902065995,0.001634603772237608,7.7,Moderate,42
rs1027128618,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31668509,N132K,Likely pathogenic,T,G,rs1027128618,31668509.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0023207690782498986,0.0032779937788207573,0.0018739776569371282,0.0010513784065967942,0.002428659118813025,0.002971836430081789,7.0,Moderate,64
rs2049618449,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31668513,E134K,Likely pathogenic,G,A,rs2049618449,31668513.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0005721112533271905,0.00047648060839429186,0.0005155967800487831,0.0006987896147572023,0.0008013983556407282,0.00036829090779494703,7.0,Moderate,18
rs1568811426,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31668514,E134G,Pathogenic,A,G,rs1568811426,31668514.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0002633786508918707,0.00020888962815041677,0.00029701691061236713,0.00033605565856397807,0.00018092692440158046,0.00029400413273101086,7.7,Moderate,11
rs1568811489,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31668538,G142V,Likely pathogenic,G,T,rs1568811489,31668538.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0009621843052259226,0.0007884562974462553,0.0009976978482128499,0.0005329354337924571,0.0012359541315032838,0.0012558778151747665,7.0,Moderate,33
rs1482760341,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31668548,L145F,Pathogenic,G,T,rs1482760341,31668548.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0002558334035708577,0.00041374568893466895,0.00022092170336467483,0.00021420507123028737,0.0002669609989657598,0.00016333355535889737,7.7,Moderate,7
rs121912447,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31668549,A146T,Likely pathogenic,G,A,rs121912447,31668549.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0009229445910255011,0.0010326495233038747,0.0013135748919414522,0.0004790853955509798,0.0010569388915432085,0.0007324742527879902,7.0,Moderate,31
rs1131690781,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31668550,A146V,Likely pathogenic,C,T,rs1131690781,31668550.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0005082981665338021,0.0006108401337617629,0.0005031203120041651,0.0005070284056624796,0.0003655303648063846,0.0005549716164342185,7.0,Moderate,17
21:31668551,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),Deletion,frameshift variant,21,31668551,C147fs,Likely pathogenic,N,-,21:31668551,31668551.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0008782502503217396,0.0009283716500557273,0.0011449837976171787,0.0004883291116458466,0.0008454371178564382,0.0009841295744335075,9.8,Severe,25
rs1568811515,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31668552,C147R,Likely pathogenic,T,C,rs1568811515,31668552.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0017704937837605985,0.0017179706823758885,0.0017226880672402208,0.0015418564071060928,0.0019075147886972292,0.001962438973383562,7.0,Moderate,60
rs1424014997,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31668562,I150S,Likely pathogenic,T,G,rs1424014997,31668562.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0023860382377533665,0.003225463488489468,0.00255411821263266,0.0030252838556553718,0.0018263228413785933,0.001299002790610739,7.0,Moderate,69
rs1424014997,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31668562,I150N,Likely pathogenic,T,A,rs1424014997,31668562.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.0017618025629096985,0.0017945573728701284,0.0014127860131578653,0.0015769489475031774,0.001817087781821003,0.0022076326991963173,7.0,Moderate,50
rs2123437030,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31668563,I150M,Likely pathogenic,T,G,rs2123437030,31668563.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.00032667408675859304,0.00041119127873873564,0.00035278980843666706,0.00016588375498289334,0.00023421427210442586,0.0004692913195302433,7.0,Moderate,7
21:31668568,SOD1,Amyotrophic lateral sclerosis type 1 (ALS1),single nucleotide variant,missense variant,21,31668568,I152N,Likely pathogenic,T,A,21:31668568,31668568.0,SOD1,21,ALS1_Classical,Adult,40-60 years,Variable,0.8,"First ALS gene discovered; 20% of familial ALS; A4V aggressive, D90A slow",7.0,0.000506631169667616,0.0006330656138524666,0.000447124470202051,0.0005086322189998107,0.00034448570989788186,0.0005998478353858699,7.0,Moderate,15
rs2145927350,CHCHD10,"Amyotrophic lateral sclerosis, mitochondrial type",Indel,missense variant,22,23767590 - 23767591,R15L,Pathogenic,N,-,rs2145927350,23767590.0,CHCHD10,22,ALS_Mitochondrial,Adult,40-60 years,Variable,0.7,Mitochondrial dysfunction; may have myopathy,6.0,0.0002255533580168165,0.00022513694650412637,0.0002252158731259307,0.00023836597603382333,0.00017425747804242125,0.00026479051637778086,6.6,Moderate,5
rs387906710,UBQLN2,Amyotrophic lateral sclerosis type 15 (ALS15) - X-linked,single nucleotide variant,missense variant,X,56565362,P497S,Pathogenic,C,T,rs387906710,56565362.0,UBQLN2,X,ALS15_XLinked,Adult,20-50 years,Moderate,0.75,X-linked dominant; males more severely affected,7.0,0.0015546883626505025,0.0017635351687862952,0.0012753839775723396,0.0010238204965092482,0.001882405248841441,0.001828296921543189,7.7,Moderate,51
rs387906709,UBQLN2,Amyotrophic lateral sclerosis type 15 (ALS15) - X-linked,single nucleotide variant,missense variant,X,56565363,P497H,Pathogenic,C,A,rs387906709,56565363.0,UBQLN2,X,ALS15_XLinked,Adult,20-50 years,Moderate,0.75,X-linked dominant; males more severely affected,7.0,0.00033209621657897626,0.0003491852769993867,0.00029833967129790903,0.0002919229922491968,0.0004092758708360038,0.00031175727151238486,7.7,Moderate,8
rs387906711,UBQLN2,Amyotrophic lateral sclerosis type 15 (ALS15) - X-linked,single nucleotide variant,missense variant,X,56565389,P506T,Pathogenic,C,A,rs387906711,56565389.0,UBQLN2,X,ALS15_XLinked,Adult,20-50 years,Moderate,0.75,X-linked dominant; males more severely affected,7.0,0.0011162524092227337,0.0012260230071851235,0.0015698436033186754,0.0008785073863204443,0.0010554335339921248,0.0008514545152973015,7.7,Moderate,32
rs2519963370,UBQLN2,Amyotrophic lateral sclerosis type 15 (ALS15) - X-linked,single nucleotide variant,missense variant,X,56565390,P506L,Likely pathogenic,C,T,rs2519963370,56565390.0,UBQLN2,X,ALS15_XLinked,Adult,20-50 years,Moderate,0.75,X-linked dominant; males more severely affected,7.0,0.001767296591798571,0.0015502812753903318,0.0025187370418294427,0.0011989658034322825,0.0013207722063098175,0.0022477266320309803,7.0,Moderate,63
X:56565536,UBQLN2,Amyotrophic lateral sclerosis type 15 (ALS15) - X-linked,single nucleotide variant,missense variant,X,56565536,P555S,Likely pathogenic,C,T,X:56565536,56565536.0,UBQLN2,X,ALS15_XLinked,Adult,20-50 years,Moderate,0.75,X-linked dominant; males more severely affected,7.0,0.0004954277966713394,0.0007653311899507294,0.0004105162521905273,0.0005608637659001179,0.00038718855600443103,0.0003532392193108911,7.0,Moderate,14
